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PAMP  pathogen associated molecular pattern 
PNI  pronuclear injection  
PCR  polymerase chain reaction 
PRR   pattern-recognition receptor 
PSp  para-aortic splanchnopleura 
ROS  reactive oxygen species 
TIR  Toll-IL-1 receptor  
TLR  Toll like receptor 
TPO  thrombopoietin 
T1D  Type 1 diabetes mellitus 
wt  wild type 
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Toll like receptors (TLRs) are critically important in the pathogen recognition and 
regulation of the innate and adaptive immune response (Akira et al. 2001; Medzhitov 
2007). In addition, it has been recently shown that direct pathogen sensing of bone 
marrow hematopoietic stem cells (HSCs) and hematopoietic progenitors via TLRs seems 
to play a crucial role in directing the hematopoietic cell fates under inflammatory 
conditions (Nagai et al. 2006; Sioud et al. 2006; Boiko and Borghesi 2011). 
 
In the past decades the role of TLRs in adult hematopoiesis and immune responses has 
been studied intensively. However, their expression pattern and role in early stages of 
embryonic development are so far largely overlooked. 
 
The presented thesis is based on three manuscripts and an overview of my current work 
focused on the role of TLRs in early embryonic hematopoietic events including 
generation of two transgenic mice strains. 
 
The first chapter is based on a manuscript (submitted to Genes and Development, in 
revision) that describes the existence of TLR2+ erythro-myeloid progenitors in very early 
stages of embryonic development.  
 
The following chapter describes the generation of two transgenic TLR2-reporter mouse 
strains suitable for lineage tracing of cells with activated Tlr2 regulatory elements 
(unpublished data). 
 
The third chapter is represented by a published article that characterizes the role of 
embryonic, yolk sac derived phagocytes expressing TLRs in developmental homeostasis 
and iron metabolism. 
 
Finally, the last two chapters include two papers dedicated to the role of myeloid cells in 
disease. One paper describes the induction of autophagy pathway in macrophages at the 
early time of Francisella tularensis LVS infection. The other paper reveals the role of 
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Toll like receptors (TLRs) are germline-encoded pattern recognition receptors (PRRs) 
that play a central role in host cell recognition and responses to pathogens. Primarily 
they are responsible for induction and regulation of the innate and adaptive immune 
responses whereby the effector function is executed chiefly by differentiated myeloid 
cells. Somewhat unexpectedly, TLRs have been also shown to be involved in direct 
pathogen sensing by bone marrow-derived hematopoietic stem cells (HSCs) and 
hematopoietic progenitors when, under inflammatory conditions, the rapid generation of 
innate immune effector cells that effectively combat the infection is of utmost priority. 
While it has been recognized that the release of inflammatory cytokines from inflamed 
tissues along with the changes in proportions of differentiating cells in the bone marrow 
(BM) as well as the BM niche can nudge the differentiation of adult BM-derived cells 
towards myeloid cells and granulocytes, a direct role of TLRs expressed by HSCs in this 
process has been demonstrated only recently. However, whether a similar mechanism 
operates also during embryonic hematopoiesis is unknown. Here we show that TLRs and 
their adaptor proteins are functionally expressed during early stages of embryogenesis 
by short-lived maternally-transferred myeloid cells, which are then replaced by 
differentiated embryonic myeloid cells. Unexpectedly, the earliest hematopoietic 
multipotent progenitors, which appear at day 6.5 of mouse embryogenesis (E6.5), also 
express TLRs and similar to differentiated embryonic myeloid cells, respond to TLR2 
triggering by enhanced proliferation and myeloid differentiation rates in a MyD88-
adaptor protein-dependent manner. In order to trace the relationship of established 
hematopoietic lineages to these TLR2+ early hematopoietic progenitors, we describe here 
the generation of two transgenic Tlr2-reporter mouse strains that enable a direct lineage 
tracing of embryonic cells with an active Tlr2 locus. In addition to providing gene 
expression profiling and multiple lines of evidence for the functionality of embryonically 
expressed TLRs, we demonstrate the involvement of TLR2 signaling in the regulation of 
iron metabolism pathway in E10.5 TLR2+ yolk sac-derived macrophages. In respect to the 
role of myeloid cells in health and disease, particularly focusing on pathogen-host 
interactions, we describe the early activation of Francisella tularensis-triggered 
autophagy pathway in macrophages which is controlled by the adaptor protein p62, a 
process that is likely initiated by TLR triggering. Lastly, we also show that myeloid α-
defensins and myeloperoxidase are highly expressed in eosinophils that are isolated from 
peripheral capillary blood of patients with the type 1 diabetes, where they could serve as 
molecular markers of transcriptionally active eosinophils. Collectively, our work 





Receptory odvozené od receptoru Toll (TLR) rozeznávají specifické evolučně 
konzervované struktury společné mnohým patogenům a hrají klíčovou roli v 
jejich rozpoznání a eliminaci hostitelem. V první řadě jsou zodpovědné za iniciaci a 
regulaci vrozené i speficické imunitní odpovědi, která je zprostředkována zejména 
diferenciovanými myeloidními buňkami. Poněkud překvapivé je nedávné zjištění, že 
v průběhu zánětlivé odpovědi, kdy je prioritou organismu produkovat dostatečné 
množství buněk imunitního systému pro boj s infekcí, hematopoetické kmenové buňky 
(HKB) a jejich progenitory mohou prostřednictvím TLR přímo rozpoznávat mikrobiální 
struktury. Tento nedávno popsaný mechanismus můžeme zahrnout mezi další již dříve 
popsané způsoby indukce diferenciace HKB v myeloidní buňky a granulocyty. Jmenovitě 
vliv zánětlivých cytokinů produkovaných infikovanou tkání a reakci na pokles počtu 
diferencovaných buněk, či jejich prekurzorů, v důsledku mobilizace těchto buněk z kostní 
dřeni. Není nicméně známo, zda se tento mechanismus uplatňuje také v embryonální 
krvetvorbě. Naše výsledky ukazují, že receptory TLR a jejich adaptorové proteiny jsou 
v časných stádiích embryogeneze funkčně exprimovány nejprve maternálními 
myeloidními buňkami, které jsou postupně nahrazeny diferenciovanými embryonálními 
fagocyty. Za povšimnutí stojí fakt, že stejně jako diferencované embryonální myeloidní 
buňky, i nejčasnější hematopoetické multipotentní progenitory, které se objevující ve dni 
6.5 embryonálního (E6.5) vývoje myši exprimují receptory TLR, a po stimulaci agonistou 
receptoru TLR2 odpovídají zvýšením úrovně proliferace a myeloidní diferenciace 
v závislosti na přítomnosti adaptorového proteinu MyD88. Abychom porozuměli 
vztahům vznikajících hematopoetických linií a TLR2+ časných embryonálních 
hematopoetických progenitorů, vytvořili jsme dva transgenní Tlr2-reportérové myší 
modely umožňující neinvazivní genetické sledování embryonálních buněk s aktivním 
lokusem genu Tlr2. Vedle zmapování expresního profilu E10.5 embryonálních fagocytů 
pocházejících vývojově ze žloutkového váčku, a prověření funkčnosti jejich receptorů 
TLR, naše data ukazují i na účast signalizace TLR2 v regulaci metabolismu železa v těchto 
embryonálních makrofázích. S ohledem na roli myeloidních buněk v rozvoji onemocnění, 
a to zejména při interakci patogen-hostitel, popisujeme časnou aktivaci autofagie 
indukované v makrofázích po infekci bakterií Francisella tularensis prostřednictvím 
adaptorového proteinu p62. Tento proces může být spuštěn aktivací receptorů TLR. 
Následně demonstrujeme, že myeloidní α-defensiny a myeloperoxidáza jsou 
produkovány eosinofily izolovanými z kapilární krve pacientů s diabetem 1. typu a mohly 
by tak představovat molekulární markery transkripčně aktivních eosinofilů. Naše práce 
poukazuje na doposud nepopsané funkce receptorů TLR v myeloidních buňkách 
v průběhu vývoje i patologických stavů.  
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1. Literature review 
1.1. Toll like receptors 
Toll like receptors are critically important in triggering immune responses to infections. 
The interaction of TLRs with their ligands initiates several distinct signaling pathways 
resulting in global and robust changes in the gene expression leading to effective innate 
immune responses and regulated development of antigen-specific immunity (reviewed in 
(Akira et al. 2001; Medzhitov 2007).  
1.1.1. TLR discovery 
Originally, the Toll gene was described to be responsible for the dorso-ventral patterning 
in developing Drosophila embryo (Anderson et al. 1985). Later, the striking structural 
and functional similarities in Toll/dorsal signaling cascade and cytokine induced 
activation of NF-kB pathway in mammals led the team of Jules Hoffman to the discovery 
of new function for Toll receptor in Drosophila immune responses to fungal infections 
(Lemaitre et al. 1996). One year later, a mammalian homolog of the Toll receptor, 
currently known as TLR4, was shown to induce the expression of genes involved in 
inflammatory responses (Medzhitov et al. 1997). This seminal observation was quickly 
complemented by an excellent study by Beutler and colleagues who identified murine 
TLR4 as a key signal-transducing receptor for LPS (Poltorak et al. 1998). Subsequent 
intense database search identified 10 human and 12 murine TLRs that recognize other 
immunologically-relevant microbial structures such as proteins, lipoproteins, 
carbohydrates and nucleic acids, as depicted in Figure 1 (Kumar et al. 2011). TLR1-TLR9 
are conserved between the human and mouse, whereas functional TLR10 is expressed 
only in humans. In contrast, mice express also TLR11, TLR12 and TLR13 which lack 
functional homologs in humans (Akira and Takeda 2004). TLRs were the first identified 
pattern-recognition receptors (PRRs) that recognize molecular structures broadly shared 
by pathogens, known as pathogen-associated molecular patterns (PAMPs). It is of 
historical interest that while the existence of PRRs was predicted by Charlie Janeway 
several years before their discovery (Janeway 1989), Bruce Beutler and Jules Hoffman 
received the Nobel prize in 2011 for the experimental demonstration of their importance 







1.1.2. TLR structure, specificity and localization 
The TLRs are the type I integral membrane glycoproteins consisting of an extracellular 
domain with 19-25 tandem copies of leucine-rich repeats, a single transmembrane 
segment and an intracellular domain, highly similar to the IL-1 receptor domain (TIR; 
Toll-IL-1 receptor) (Akira et al. 2006). Despite this similarity, the extracellular portions 
of both types of receptors are structurally unrelated allowing recognition of a wide 
spectrum of non-self ligands (Akira and Takeda 2004). These include lipoproteins 
(recognized by TLR1, TLR2, and TLR6), double-stranded RNA (TLR3), lipopolysaccharide 
(TLR4), flagellin (TLR5), single-stranded RNA (TLR7 and TLR8), and DNA (TLR9) (Figure 
1) (Akira et al. 2006).  
 
Based on cellular localization, two groups of TLRs can be distinguished: TLR1, TLR2, 
TLR4, TLR5, and TLR6 are localized on the cell surface and largely recognize microbial 
membrane components whereas TLR3, TLR7, TLR8, TLR9, TLR11 and TLR13 are 
expressed within intracellular vesicles and recognize mainly nucleic acids (Blasius and 
Beutler 2010). The intracellular localization within innate immune cells enables TLRs to 
recognize nucleic acids delivered to the intracellular compartments after the uptake of 
viruses and other pathogens or infected cells and prevents their activation by harmless 
nucleic acids present in the cytosol. However, there are some exemptions from the 
“localization” rule as on fibroblasts/endothelial cells and human neutrophils, TLR3 and 
TLR9 respectively, are expressed also as surface receptors (Lindau et al. 2013; Miyake 
and Onji 2013; Pohar et al. 2013).  
 
Figure 1. TLR-mediated immune responses; taken from (Kawai and Akira 2006). 
TLR2 in concert with TLR1 or TLR6 discriminates between the molecular patterns of triacyl and diacyl 
lipopeptide, respectively. TLR3 recognizes dsRNA. TLR4 recognizes bacterial LPS. TLR7/8 mediates 
recognition of imidazoquinolines and ssRNA. TLR9 recognizes CpG DNA of bacteria and viruses. TLR5 
recognizes flagellin and mouse TLR11 recognizes components of uropathogenic bacteria and profilin-
like molecule of the Toxoplasma gondii. TLR1/2 and TLR2/6 utilize MyD88 and TIRAP/MAL as essential 
adapters. TLR3 utilizes Trif. TLR4 utilizes MyD88, TIRAP/MAL, Trif and TRAM. TLR7/8, TLR9, TLR5 and 
TLR11 use only MyD88.  
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1.1.3. TLR signaling pathways 
Upon ligand binding, TLRs dimerise and recruit proximal TIR-domain containing adaptor 
proteins initiating downstream signaling leading to the activation of transcription factors 
such as NF-κB, IRFs and AP-1. The outcome of the response is dependent on the type of 
adaptor protein or their combination used. So far, five TLR adaptor proteins, acting alone 
or in combination, have been described: MyD88, MAL, TRIF, TRAM and SARM, reviewed 
in (Dunne and O'Neill 2003; Kawai and Akira 2010) (Figure 2, (Kawai and Akira 2011). 
MyD88 is utilized by all TLRs (with the exception of TLR3) and members of IL-1R family 
and transmits signals culminating in NF-kB and MAP kinase activation and the induction 
of inflammatory cytokines. TLR3 and TLR4 use TRIF to activate an alternative pathway 
leading to the activation of NF-kB and IRF3 and the induction of type I IFN and 
inflammatory cytokine productions. TLR2 and TLR4 use TIRAP as an additional adaptor 
to recruit MyD88. TRAM acts as a bridge between TLR4 and TRIF (Kawai and Akira 
2011). TLR4 is the solely TLR that activates two distinct signaling pathways involving 
MyD88 or TRIF adaptors with a different kinetics. Initially, surface TLR4 recruits TIRAP 
and MyD88. Subsequently, MyD88 recruits IRAKs, TRAF6, and the TAK1 complex, leading 
to early-phase activation of NF-kB and MAP kinases (Kawai and Akira 2010). TLR4 is 
then endocytosed and delivered to intracellular vesicles to form a complex with TRAM 
and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi, which 
catalyze the phosphorylation of IRF3, leading to the expression of type I IFN (Barton and 
Kagan 2009). TRAM-TRIF also recruits TRAF6 and TAK1 to mediate late-phase activation 
of NF-kB and MAP kinases. Whereas type I IFN response is elicited upon TRIF 
recruitment, the robust NF-kB and MAP kinase activation followed by the induction of 
inflammatory response demands utilization of both MyD88 and TRIF. Accordingly, TLR2-
TLR1 and TLR2-TLR6 heterodimers that signal through TIRAP and MyD88, are recruited 
to the phagosome during phagocytosis of zymosan or Staphylococcus aureus to induce the 
production of inflammatory cytokines (Kawai and Akira 2011). In addition, TLR2 is 
capable to induce type I IFN in inflammatory monocytes infected with vaccinia viruses 
(Barbalat et al. 2009). TLR7 and TLR9 are exclusively expressed in plasmacytoid DCs 
(pDCs), which have the capacity to secrete vast amounts of type I IFN rapidly in response 
to viral infection in a MyD88 dependent manner (Gilliet et al. 2008; Reizis et al. 2011). 
One recent study suggests that TLR5, which normally signals from the surface through 
MyD88 to elicit inflammatory cytokine production, in intestinal epithelial cells recruits 
TRIF in addition to MyD88, which leads to the activation of NF-kB rather than IRF3 (Choi 








Figure 2. TLR-mediated immune response; taken from  (Kawai and Akira 2011). 
Individual TLRs initiate overlapping and distinct signaling pathways in various cell types such as 
macrophages (MP), conventinal DC (cDC), plasmacytoid DC (pDC), lamina propria DC (LPDC), and 
inflammatory monocytes (iMO). PAMP engagement induces conformational changes of TLRs that allow 
homo- or heterophilic interactions of TLRs and recruitment of adaptor proteins (MyD88, TIRAP, TRIF, 
and TRAM). TLR5, highly expressed on the cell surface of LPDC, uses MyD88 and activates NF-kB 
through IRAKs, TRAF6, TAK1, and IKK complex, resulting in induction of inflammatory cytokines. 
Heterodimers of TLR1- TLR2 and TLR2-TLR6 are also expressed on the cell surface and induce NF-kB 
activation through recruitment of TIRAP and MyD88 in MPs and cDCs. In iMO, TLR2 is found to be 
expressed within the endosome and induce type I IFN via IRF3 and IRF7 in response to viruses. TLR4, 
which is expressed on the cell surface, initially transmits signals for the early-phase activation of NF-kB 
by recruiting TIRAP and MyD88. TLR4 is then transported into Rab11a
+
 phagosomes that contain 
bacteria, where it recruits TRAM and TRIF and activates TRAF3-TBK1-IRF3 axis as well as late-phase NF-
kB activation for the induction of type I IFN. Both early- and late-phase activation of NF-kB is required 
for the induction of inflammatory cytokines. TLR3, TLR7, and TLR9 are localized mainly to the ER in the 
steady state and traffic to the endosomal compartment, where they engage with their ligands. TLR3 
activates the TRIF-dependent pathway to induce type I IFN and inflammatory cytokines in MPs and 
cDCs. In pDCs, TLR7and TLR9 activate NF-kB and IRF7 via MyD88 to induce inflammatory cytokines and 
type I interferon, respectively. The activation of NF-kB during TLR7 and TLR9 signaling is initiated from 
the endosome whereas IRF7 activation is initiated from the lysosome-related organelle (LRO) after TLR7 
and TLR9 are transported from the endosome to this vesicle in a manner dependent on AP3. MyD88-
dependent IRF7 activation in pDCs is mediated by activation of IRAK1, TRAF6, TRAF3, and IKKa and is 
facilitated by IFN-inducible Viperin expressed in the lipid body. In cDCs and MPs, TLR7 and TLR9 induce 





1.1.4. TLR expression 
Recognized as the sensors for danger signals, TLRs are expressed mainly by innate 
immune cells  such as macrophages, monocytes, dendritic cells, granulocytes and NK cells 
(Hornung et al. 2002; Sabroe et al. 2002; Nagase et al. 2003), but also by other, more 
specialized types of immune and nonimmune cells – B and T lymphocytes (Bourke et al. 
2003; Caramalho et al. 2003), keratinocytes and other epithelial cells (Gewirtz et al. 
2001; Saint André et al. 2002; Wolfs et al. 2002; Pivarcsi et al. 2003). 
 
Recently, hematopoietic stem cells (HSCs) and hematopoietic progenitors have been 
shown to express TLRs allowing them to directly sense the presence of infections (Nagai 
et al. 2006; Sioud et al. 2006; De Luca et al. 2009). While in unperturbed physiological 
circumstances bone marrow (BM) hematopoiesis is driven by a lineage specific 
combination of endogenous cytokines and growth factors secreted in situ by cells 
residing in the hematopoietic niche or from a remote site (Alexander 1998), it has been 
demonstrated that TLR stimulation can nudge the BM hematopoiesis towards the 
increased production of granulocytes, monocytes and monocytic dendritic cells (Ueda et 
al. 2005; Nagai et al. 2006; Sioud et al. 2006). For the first time, in 2006, Nagai and 
colleagues have shown that HSCs and hematopoietic progenitors express TLRs, the 
immune system triggers. According to their findings, TLR ligands drove normal but not 
MyD88-deficient HSCs and multipotent progenitors (MPPs) to proliferate and increased 
their output of differentiated progeny and supported the common lymphoid progenitors 
(CLPs) to preferentially differentiate into CD11c+ dendritic cells (Figure 3). Shortly after, 
the expression of TLRs and TLR-signaling driven instruction for a myeloid cell fate were 
described for human BM CD34+ cells (Sioud et al. 2006) and human HSCs (De Luca et al. 
2009).  
 
Thus sensing of danger signals by TLRs expressed on HSCs and hematopoietic 
progenitors serves as an important back-up mechanism operating during the course of 
infection when rapid replenishment of short-lived myeloid cells is crucial for the 













Figure 3. Hematopoiesis under steady-state and inflammatory conditions; taken from (Holl and 
Kelsoe 2006). 
All hematopoietic lineages arise from a common ancestor, the hematopoietic stem cell (HSC). In turn, 
the self-renewing HSC gives rise to progenitor cells with more limited developmental plasticity through 
asymmetric division. Committed myeloid progenitors (CMPs) and committed lymphoid progenitors 
(CLPs) are multipotent cells incapable of self-renewal but under normal, steady-state conditions (left) 
generate all differentiated myeloid and erythroid (CMP) or lymphoid (CLP) cell types. CLPs differentiate 
to B or T lymphocytes under the influence of IL-7, to NK cells with IL-15, or to DCs. CMPs produce even 
more differentiated granulocyte and monocyte progenitors (GMP) that respond to granulocyte colony 
stimulating factor (G-CSF) or macrophage colony stimulating factor (M-CSF) by differentiating to 
granulocytes or macrophages, respectively. Megakaryocyte and erythroid progenitors (MEPs) are 
driven by thrombopoietin (TPO) or erythropoietin (EPO) to form, respectively, megakaryocytes or 
erythrocytes. In the presence of the TLR ligands LPS and Pam3CSK4 (right), HSC and more differentiated 
progenitors bearing TLR2 and/or TLR4 respond by altering hematopoietic output. GMPs become 
capable of producing granulocytes and macrophages in the absence of G-CSF or M-CSF, and while 
lymphocyte production by CLPs is reduced, DC output becomes increased. Generation of 










While it was generally accepted, that HSCs are sheltered from the danger signals by their 
BM niches, several groups have recently shown that HSCs and hematopoietic stem and 
progenitor cells (HSPCs) are constitutively circulating though the blood stream between 
the BM and peripheral organs (Figure 4)(Wright et al. 2001). This process is believed to 
be critical in the maintenance of normal hematopoietic homeostasis in dispersed BM 
cavities (Wright et al. 2001), but also enables the pathogen recognition receptors-bearing 
HSPCs to patrol the immune periphery (Massberg et al. 2007). Indeed, the migratory pool 
of HSPCs might act as a source of highly versatile stem and progenitor cells that can 
respond to danger signals locally within tissues before the information is spread to the 
BM (Nagai et al. 2006; Massberg et al. 2007). Notably, TLR stimulation also prevents 
HSPCs to exit from inflamed tissues (Massberg et al. 2007).  
 
 
Figure 4. Migration of Hematopoietic Stem and Progenitor Cells; taken from (Welner and Kincade 
2007). 
(1) Many stem cells reside in association with osteoblasts in trabecular bone. (2) An even greater 
number are close to centrally located vascular sinuses, but little is known about exchange between 
these two locations. (3) PAMPs and cytokines released during infection can mobilize hematopoietic 
stem and progenitor cells (HSPCs), which migrate out of the BM into blood, but small numbers exit 
under normal circumstances. HSPCs remain in the circulation for only seconds but reside in tissues such 
as the lungs, liver, and spleen for at least 36 hr. (4) Their stay is extended by recognition of PAMPs by 
TLRs that they express. Myeloid cells are produced locally from HSPCs in response to particular TLR 
ligands, and these effectors of the innate immune system presumably fight infections and promote 
tissue repair. (5) Unstimulated HSPCs use their sphingosine-1-phosphate receptors to recognize steep 
gradients of sphingosine-1-phosphate and to enter the lymph (blue). (6) HSPCs quickly transit through 
one or more lymph nodes before returning to the blood via the thoracic duct. (7) At least some stem 





1.2. Hematopoietic stem cells 
During the lifetime, all blood cells, including red blood cells, megakaryocytes, myeloid 
cells (monocyte/macrophage and neutrophil) and lymphocytes are continually produced 
in the BM through the expansion and differentiation of progenitors that originate from a 
scarce cell population, the long-term hematopoietic stem cells (LT-HSCs). LT-HSCs, that 
sit atop a hierarchy of hematopoietic progenitors, are capable of extensive self-renewal 
capacity and ability to differentiate to short-term HSCs and lineage restricted progenitors 
(Orkin and Zon 2008). Under steady-state conditions, HSCs divide infrequently and are 
found mainly in the G0 phase of cell cycle (Trumpp et al. 2010).  
 
Initially, HSCs were identified based on their ability to form colonies in the spleens of 
lethally irradiated mice upon BM transfer (Till and McCulloch 1961). With contemporary 
methods, HSCs may be highly purified such that as few as one cell may provide long-term 
hematopoietic reconstitution in a recipient. All functional HSCs are found among the 
lineage (Lin) negative, stem-cell antigen 1 (Sca1) and c-kit positive (LSK) fraction of BM 
cells. 
 
However, there is a consensus that no ex vivo functional assays can replace in vivo 
transplantation for measuring biological activity of HSCs. Similarly, the characterization 
of LT-HSC cell populations, based solely on the expression profile of cell surface markers, 
cannot be considered synonymous with determining their function. In this respect, LT-
HSCs are defined on the basis of their functional ability to provide a long-term 
hematopoietic reconstitution in myeloablated hosts. A sustained output of ≥ 1% of all the 
circulating white blood cells for ≥ 4 months is considered as a „gold standard“ to define 
multipotency of LT-HSCs (Purton and Scadden 2007).  
 
As HSCs divide and pass developmental branch points they become more restricted and 
ultimately yield unipotent progenitor cells. The lineage restriction, which occurs at each 
branch point, is also referred to as “cell fate decision” or “lineage commitment”. 
Visualization of these branching events via a cartoon map provides essential information 
about the relationships between these lineages. According to a textbook model, 
formulated approximately 30 years ago, HSCs generate the common myeloid-erythroid 
progenitors (CMEP) and a common lymphoid progenitors (CLP), which produce myeloid 
or erythroid cells and T or B cells, respectively. Apart from this “classical model” of 
lineage commitment, in 2001, the so-called “myeloid-based” model was proposed by 
Kawamoto and colleagues (Katsura and Kawamoto 2001). It posits that HSCs first 
diverge into the CMEPs and the common myelo-lymphoid progenitors (CMLPs), which 
generate T and B cell progenitors through a bipotential myeloid-T progenitor and a 
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myeloid-B progenitor stage. Thus the potential to generate myeloid cells is retained in all, 




Figure 5. Representative models of hematopoiesis; taken from (Kawamoto et al. 2010).  
(A) This model proposes that the HSC firstly diverges into a CMEP and a CLP. Note that CMEPs are 
sometimes referred to as common myeloid progenitors (CMPs). E, M, T and B represent the progenitor 
potential for erythroid, myeloid, T and B cells, respectively. (B) In this model, the first branch point 
generates CMEPs and CMLPs, and the myeloid potential persists in the T and B cell branches even after 
these lineages have diverged. 
 
1.2.1. The ontogeny of mammalian hematopoiesis 
The mammalian hematopoiesis is established during embryonic development via a 
successive passage of hematopoietic cells through several anatomic niches where they 
originate, expand or differentiate (Figure 6)(Costa et al. 2012). 
 
The onset of hematopoiesis is tightly coupled with gastrulation, a morphogenetic event 
through which the three definitive germ layers, ectoderm, mesoderm and endoderm, are 
established (Tam and Beddington 1987; Ferkowicz and Yoder 2005). During this process, 
the formation of the yolk sac (YS) is initiated from the primitive streak, a region of 
epiblast in close proximity to extra-embryonic ectoderm around E6.5 (Gardner and 
Rossant 1979; Lawson et al. 1991). Developmentally, the YS is established by the 
contribution of extra-embryonic visceral endoderm and extra-embryonic mesoderm 
generated by ingression of the most posterior epiblast cells located close to extra-
embryonic ectoderm (Smith et al. 1994). Later, cells ingressing from the middle and 
anterior streak regions form intra-embryonic mesoderm including the future aorta gonad 
mesonephros (AGM) region (Tam and Beddington 1987). The very first blood cells are 
detected between E7.0-E7.5 in the YS blood island, with a predominant emergence of 
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primitive nucleated erythroblasts expressing embryonic and fetal forms of hemoglobin 
(Silver and Palis 1997). This first wave of hematopoiesis is generally called primitive 
hematopoiesis/erythropoiesis (Golub and Cumano 2013). In addition, differentiated 
macrophages and megakaryocytes start to appear in the YS blood island, arising probably 
from the hemangioblast precursor migrating from the posterior primitive streak around 
E7.25 (Moore and Metcalf 1970; Palis et al. 1999; Xu et al. 2001; Huber et al. 2004; 
Ferkowicz and Yoder 2005).  
 
However, these YS-derived precursors are not considered HSCs as they are incapable of 
long term multi-lineage reconstitution (LTML) of irradiated adult host unless 
conditioned in appropriate environment (the co-culture with AGM-derived cell lines, 
remnants of fetal liver (FL) in newborn animals) (Yoder et al. 1997; Cumano et al. 2001; 
Matsuoka et al. 2001).  
 
The first bona fide HSCs emerge from the hemogenic endothelium of the AGM at E10.5 
(Muller et al. 1994; Medvinsky and Dzierzak 1996; de Bruijn et al. 2000; Cumano et al. 
2001; Dzierzak and Medvinsky 2008). There is a growing body of evidence that the 
hemogenic endothelium derives from hemangioblast cells (Lancrin et al. 2009). 
Subsequently, AGM-derived HSCs start to successively colonize the sites of definitive 
hematopoiesis: fetal liver, spleen, thymus, and eventually bone marrow where they 
expand and differentiate (Moore and Metcalf 1970). Importantly, and in contrast to the 
YS-derived early hematopoietic precursors, their E10.5 AGM counterparts can engraft 
adult host in LTML reconstitution manner. In addition it has been recently shown, that 
after E10.5, the placenta, chorion, allantois as well as vitelline and umbilical arteries can 
provide a niche suitable for HSCs emergence (de Bruijn et al. 2000; Zeigler et al. 2006; 








Figure 6. Embryonic sites of blood development; taken from (Costa et al. 2012). 
In murine embryos, hematopoiesis takes place in several tissues where blood cells are generated and/or 
undergo maturation. The first hematopoietic progenitors are found extra-embryonically at E8.0–E8.5, 
in the YS blood islands in close proximity to emerging endothelial cells. Once circulation is established, 
blood cells colonize other developing hematopoietic organs. Around E10.5, the AGM, placenta, 
umbilical artery and vitelline artery initiate the generation of blood precursors that, together with YS 
cells, colonize to the FL rudiment around E11.5. The FL is the major hematopoietic site where blood 
progenitors expand and/or mature. Finally, the BM is colonized by precursors from the FL before birth 
and remains the main hematopoietic niche throughout adult life. 
 
What remains uncertain is the origin and developmental path leading to HSCs 
appearance in AGM (Ueno and Weissman 2007; Medvinsky et al. 2011). One model 
suggests that this process is independent from the hematopoiesis occurring in the 
visceral YS (Medvinsky and Dzierzak 1996; Cumano et al. 2001; Bertrand et al. 2005a). 
According to this view, the YS precursors, emerging at ~E7.5, provide only a transient 
and lineage-limited supply of hematopoietic progenitors (Muller et al. 1994; Medvinsky 
and Dzierzak 1996; de Bruijn et al. 2000; Cumano et al. 2001). In contrast, the second 
model posits the existence of a common founder of hematopoiesis, that emerges either 
from the YS (Moore and Metcalf 1970; Samokhvalov et al. 2007; Tanaka et al. 2012) or, 
alternatively, from mesoderm precursors in posterior primitive streak, so called 
hemangioblast, migrating concurrently towards the YS as well as para-aortic 




Figure 7. Two models of embryonic and adult blood formation; taken from (Ueno and Weissman 
2007). 
 a, The ‘separate’ model. Embryonic blood-forming cells, generated in a region called the ‘primitive 
streak’, proliferate in the yolk sac, migrate to the embryo proper, but eventually die out. The adult 
blood-forming cells, whose origin in the early-stage embryo is unknown, are separately generated in 
the aorta–gonad–mesonephros (AGM) region and later seed the adult bone marrow. b, The ‘common’ 
model. Adult blood-forming cells in the AGM regions at least partly originate from Runx1-positive 
progenitors in the yolk sac. Black and blue arrows show pathways of embryonic and adult blood-
forming cells, respectively; bold blue arrow is the pathway described by Samokhvalov and colleague 
(Samokhvalov et al. 2007). Regions of cells at the primitive-streak stage: notochord (blue); somites 
(yellow); heart and cranial mesoderm (green); extra-embryonic mesoderm (pink)(Kinder et al. 1999). 
 
Specifically, the concept of intra-embryonic AGM as a unique and independent source of 
HSCs has been challenged by a recent genetic cell-lineage tracing study showing that YS-
derived hematopoietic precursors can contribute to the pool of HSCs that give rise to 
adult hematopoietic cells (Samokhvalov et al. 2007). In this study the authors used a non-
invasive pulse–labeling system based on Cre/loxP recombination to track Runx1 
expressing cells in vivo to raise the possibility that at least a certain pool of HSCs 
originates from YS precursors. Upon genetic labeling, induced at E7.5, Runx1+ YS cells 
were found in E10.5 circulating primitive erythroid (Ter119+) and CD45+ lineages. Later, 
at E16.5, Runx1 positive cells were found among fetal (E16.5) erythro-myeloid and 
lymphoid (B and T) lineages, whereas the contribution to E12.5 YS VE-cadherin+ CD45– 
Ter119– endothelial cells was negligible. Moreover, the analysis of peripheral blood of 9-
12 month old mice revealed the contribution of E7.5 induced Runx1+ YS cells to the 
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hematopoietic system of adult mice, proving their long term repopulating capacity (1-
10%). In addition, when genetically labeled at E9.5, virtually all cells of every major blood 
cell lineage were present among labeled descendants of tagged embryonic cells. In sharp 
contrast, no embryonic or adult hematopoietic lineage was susceptible to genetic labeling 
induced at E6.5. Based on these data, the authors proposed that, by E9.5, the HSC lineage 
is fully committed and completely segregated from Runx1– mesodermal precursors, i.e. 
de novo generation of the adult HSC lineage is completed and thus, a new HSCs 
recruitment thereafter is unlikely. Hence, it is reasonable to assume, that the YS 
contributes to normal adult hematopoiesis (Samokhvalov et al. 2007).  
 
Because the accurate assessment of the site of origin of hematopoietic cells is obscured 
by extreme mobility of blood cells upon development of cardiac function, Lux and his 
colleagues used Ncx1–/– mice that lack heartbeat but their hematopoiesis is intact to 
determine the role of blood circulation on distribution of hematopoietic precursors in 
developing embryos (Ncx1–/– embryos die by E11.5). Using this model, they showed, that 
while the number of primitive erythrocytes (EryP) and definitive hematopoietic 
progenitor cells (HPC) emerging from the YS is similar among Ncx1+/– and Ncx1–/– 
embryos, the PSp region of Ncx1–/– embryos completely lacked hematopoietic cells from 
E8.25-9.5, suggesting that EryP and definitive HPC that seed the liver are ultimately 
derived from the YS (Lux et al. 2008). 
 
The lineage tracing data were further developed by Yosuke Tanaka from Samokhvalov’s 
group in 2012. To deconvolute the origin of hematopoiesis they designed an embryo-
rescue system in which Runx1 can be reactivated in Runx1–/– concepti at desired 
developmental stages. In this system, only the reactivation of Runx1 expression at E6.5-
E7.5 led to the lethal phenotype rescue, suggesting the critical ontogenetic function of 
Runx1 at this time point. Restoration of Runx1 function at E7.5 led to the full recovery of 
adult-type HSCs and entire hematopoiesis. Thus, these in vivo and ex vivo experiments 
provided compelling evidence that definitive hematopoiesis and adult type HSCs 
originate predominantly from the nascent extra-embryonic mesoderm and suggested 
that while the YS operates as a primary and sufficient source of adult type hematopoiesis, 
the AGM region is redundant for de novo blood generation and may represent a 
transitory niche for developing HSCs (Tanaka et al. 2012).  
 
Similarly, several studies have documented the occurrence of YS-derived adult myeloid 
cells independent of AGM origin (Alliot et al. 1999; Ginhoux et al. 2010; Schulz et al. 
2012). Moreover, LTML reconstitution capacity of AGM precursors is largely 
compromised if isolated from embryo <E10.5. This engraftment incompetence can be 
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regained by co-culturing them with AGM-derived stromal cells, what strongly attest to 
the importance of AGM environment in maturation of these hematopoietic precursors 
(Yoder et al. 1997; Cumano et al. 2001; Matsuoka et al. 2001). Surprisingly, it has been 
demonstrated that subjecting the YS-derived hematopoietic precursors from a 
precirculation embryo (≤E8.0) to the same co-culture system also endows them with 
LTML reconstitution capacity (Matsuoka et al. 2001). Given that embryonic blood 
circulation is gradually established from around E8.25 (McGrath et al. 2003), the cross-
migration of hematopoietic precursors from the YS to AGM, where they mature to HSCs, 
cannot be ruled out (Cumano et al. 2001; Lux et al. 2008). Taken together these studies 
further support the notion that not only AGM, but also YS-derived precursors could 
display HSC potential and thus, at least a fraction of adult HSCs could be of YS origin 
(Matsuoka et al. 2001; Samokhvalov et al. 2007; Tanaka et al. 2012). 
 
1.3. Myeloid cells in development and disease 
1.3.1. The biology of myeloid cells 
While there is probably a certain level of functional plasticity shared in all hematopoietic 
cells, there is no doubt that, except HSCs, myeloid cells are endowed with the highest 
level of plasticity (Galli et al. 2011). Adult type myeloid cells that represent the major 
leukocytes in the peripheral blood originate in the BM through the granulocyte-monocyte 
progenitor (GMP) (reviewed in (Iwasaki and Akashi 2007)).  
 
Based on integrin β7 expression GMP can be divided into two fractions. While integrin β7 
negative GMP give rise to monocytes, DCs, neutrophils and eosinophils, β7LOW GMPs 
generate mast cell and basophil precursors. The developmental scheme describing the 
generation of adult type myeloid cells is shown in Figure 8. 
 
Granulocytes (neutrophils, eosinophils and basophils) are the first cells to be recruited to 
the local sites upon pathogen invasion, providing an immediate immune response to 
infections (Kawamoto and Minato 2004).  
 
Monocytes differentiate into macrophages in peripheral tissues, where they show unique, 
tissue specific functions, but they may also differentiate to dendritic cells (DCs) in 
lymphoid organs and Langerhans cells in skin as well. DCs are professional antigen-
presenting cells that ultimately control immunity and tolerance and their complex 






Figure 8. Developmental Pathways downstream of GMP (taken from (Iwasaki and Akashi 2007)). 
Isolatable progenitors for each granulocyte lineage are shown. The GMP is divided into integrin β7– and 
β7lo populations. The latter is primed to the basophil and the mast-cell lineages: β7lo GMP presumably 
migrate into the spleen to become β7hi BMCP that give rise to β7hi intestinal MCP. β7lo GMP may also 
give rise to β7
lo
 BaPs and β7
hi
 MCP in the BM. β7
–
 GMP differentiate into β7
–
 EoP as well as MDP or 
putative NMP. The lineal relationships among these progenitor populations remain unclear. MCP, mast-
cell progenitor; BaP, basophil progenitor; BMCP, basophil/mast-cell progenitor; EoP, eosinophil 
progenitor; NMP, neutrophil-monocyte progenitor; and MDP, macrophage-dendritic-cell progenitor. 
1.3.2. Tissue-resident macrophages   
During embryogenesis, macrophages are among the first hematopoietic cells to appear. 
Starting E9.5 in the mouse, they are already dispersed throughout the embryo to 
contribute to the tissue integrity maintenance. It is now widely accepted, that under a 
steady state, major tissue-resident macrophage populations, including microglia, Kupffer 
cells of the liver, lung alveolar, splenic, and peritoneal macrophages, are established 
prenatally either from the YS or AGM/FL hematopoiesis and in adults are replenished 
independently of the BM (Ginhoux et al. 2010; Yona et al. 2013). Under inflammatory 
conditions, however, resident macrophages can be transiently complemented by Ly6C+ 
monocytes recruited from the BM (Ajami et al. 2011; Leuschner et al. 2012). 
Interestingly, it has been recently shown that two major adult tissue resident 
macrophage populations established during embryogenesis that coexist during lifetime, 
i.e. YS derived (F4/80BRIGHT) and AGM/FL derived (F4/80LOW) fractions differ in their 
dependency on Myb transcription factor and have a distinct replenishment capacity. 
Notably, in contrast to F4/80LOW Myb-dependent macrophages, the YS derived Myb-
independent F4/80BRIGHT lineage persists in adult mice independently of HSCs and cannot 




Originally described by Gordon and Hume, resident macrophages represent an incredible 
diverse set of cells employed in every aspect of organism’s biology from development, 
homeostasis, repair and immune responses (Hume et al. 1984; Wynn et al. 2013). The 
individual expression profiles of macrophages resident to particular tissues overlap only 
marginally, suggesting that they represent many unique classes of macrophages 
equipped with a transcriptome tailored to the given tissue demands (Gautier et al. 2012). 
During development they are responsible for tissue patterning, including osteogenesis 
and branching morphogenesis (mammary gland, kidney and pancreas) (Rae et al. 2007; 
Pollard 2009; Stefater Iii et al. 2011). In the BM stem cell niche, macrophages modulate 
the dynamics of hematopoietic cell release (Chow et al. 2011). As professional 
phagocytes, macrophages are involved in tissue remodeling not only during 
embryogenesis, but also in adults. Adult-type erythropoiesis is dependent on 
macrophages surrounding enucleating erythroblasts that engulf excluded erythrocyte 
nuclei (Kawane et al. 2001). Macrophages also tightly regulate angiogenesis by secreting 
angiopoietic factors as well as instructing vascular endothelial cells to apoptosis when 
not placed properly (Rao et al. 2007). Microglia shape the brain architecture as they 
promote neuron viability, modulate neuron activity and prune synapses during 
development (Pollard 2009; Paolicelli et al. 2011; Li et al. 2012b). Moreover resident 
macrophages are involved in the metabolic homeostasis by facilitating metabolic 
adaptation to cold (adipose) or increased caloric uptake (liver) and modulating insulin 
resistance upon inflammatory insult (Odegaard et al. 2007; Nguyen et al. 2011; Samuel 
and Shulman 2012).  
 
However the reparative and homeostatic functions of macrophages can be subverted by 
chronic insults, resulting in relatively common association of macrophages with disease 
states (Wynn et al. 2013). Although inflammatory macrophages are initially beneficial to 
the infected tissue, they also trigger collateral tissue damage. Moreover, if the control 
mechanism of immune response failed, macrophages can contribute to disease 
progression as seen in many chronic inflammatory or autoimmune conditions (Nathan 
and Ding 2010). Specifically, direct involvement of macrophages has been shown in 
atherosclerosis, asthma, inflammatory bowel disease, rheumatoid arthritis and diabetes 
(Marée et al. 2005; Kamada et al. 2008; Hansson and Hermansson 2011; Murray and 
Wynn 2011). In addition, macrophages have been shown to promote tumor initiation, 





Granulocytes are relatively short lived effector innate immune cells characterized by the 
presence of intracellular granules and segmented nucleus. In the absence of pro-survival 
factors, they die by apoptosis shortly after maturation (Geering et al. 2013).  Based on 
their effector functions, granule content and appearance of histological staining, three 
types of granulocytes can be distinguished: neutrophils, eosinophils and basophils.  
 
Neutrophils, the most abundant granulocytes in the blood, are equipped to kill pathogens 
in several ways. Most importantly they are capable to engulf smaller pathogens in the 
phagolysosomes and destroy them upon fusion with granules containing reactive oxygen 
species (ROS) generated by NADPH oxidase and myeloperoxidase together with 
proteolytic enzymes, cytotoxins (lysozyme) and antimicrobial peptides (defensins) 
(Borregaard et al. 2007). They are also able to release pro-inflammatory cytokines and 
pro-resolving mediators, modulate immune responses and generate neutrophil 
extracellular traps (NET) to capture extracellular pathogens (Brinkmann et al. 2004; 
Mantovani et al. 2011). Once neutrophils enter the bloodstream they are destined to 
rapidly die by apoptosis in the absence of exogenous signals. However their survival can 
be prolonged under inflammatory conditions (Summers et al. 2010). Anti-apoptotic 
signals can be delivered to neutrophils by PRRs. Specifically it has been demonstrated, 
that neutrophils express a wide spectrum of TLRs, and that their triggering leads to 
prolongation of cell lifespan (Francois et al. 2005). TLR signaling has been shown to have 
multiple effects in neutrophils, including cytokine production, ROS generation, receptor 
expression and phagocytosis (Hayashi et al. 2003). 
 
Eosinophils are characterized by a bi-lobed nucleus with highly condensed chromatin 
and the presence of granules containing eosinophil peroxidase, eosinophil 
lysophospholipase and cationic proteins (Yousefi et al. 2012). They spend only a short 
time in the blood stream before they localize to the thymus, spleen, lymph nodes or 
gastro-intestinal tract where they home under physiological conditions. In response to 
inflammatory signals, eosinophils migrate to peripheral tissues where their survival is 
prolonged and they start to secrete their products into the surrounding tissue, thereby 
triggering local inflammation and tissue remodeling (Weller 1994; Gleich 2000). 
Although not being “professional” antigen presenting cells, eosinophils can process 
antigens, and stimulate T cells in an antigen specific manner (Wang et al. 2007). They are 
also able to shape TH1/TH2 T cell differentiation (Spencer et al. 2009). In comparison to 
neutrophils, eosinophils express fewer TLRs and their responsiveness has been so far 
demonstrated only to TLR2, TLR5 and TLR7 ligands. In eosinophils, TLR triggering can 
lead to the induction of adhesion molecules and pro-inflammatory cytokine expression as 
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well as ROS generation, suggesting that they can participate in the recognition and killing 
of pathogens (Wong et al. 2007). A tightly controlled degranulation (piecemeal 
degranulation) is a prominent eosinophil function, enabling the release of bactericidal 
cationic proteins in the extracellular space (Lehrer et al. 1989).  Another bactericidal 
mechanism employed by eosinophils is the formation of eosinophil extracellular traps 
containing bactericidal granule proteins and mitochondrial DNA (Yousefi et al. 2008). 
However, the function of eosinophils in health and disease remains elusive. Although 
eosinophils are often found in some tissue pathologies (asthma, eosinophilic 
oesophagitis, helmint infections), whether and how they are involved in the onset or 
outcome of these diseases is largely unknown (Rosenberg et al. 2013).  
 
Basophils represent the rarest population of granulocytes. Like eosinophils, they contain 
bi-lobular nucleus and basophilic granules. Their granules contain biologically active 
molecules as histamine and heparin. While they share many common features with mast 
cells (histamine, high affinity IgE receptor) they differ in lack of c-kit on their surface, 
their maturation pathway in the BM and shorter lifespan. Like eosinophils, basophils play 
a role in parasitic infections, allergies and induction of TH2 responses (Min et al. 2012; 
Suurmond et al. 2014). They are usually found in tissues where allergic reactions occur 
and thus likely contribute to the severity of these reactions. Basophils also represent a 
substantial source of a TH2 promoting cytokines IL-4 and IL-13, both of which are critical 
in the pathogenesis of allergies. However, it seems unlikely, that basophils serve as 
antigen presenting cells (Schroeder et al. 2001; Suurmond et al. 2014). Several reports 
have identified TLRs expressed in basophils, suggesting that specific ligands for these 
receptors play a role in modulating mediator release and cytokine secretion. While 
basophil viability or adhesion molecule induction is not influenced by TLR triggering 
(Komiya et al. 2006), TLR2/6 ligand, peptidoglycan, was shown to induce secretion of IL-
4 and IL-13 from basophils although in lower levels than upon IgE/FcεRI cross-linking 
(Bieneman et al. 2005). Recently, the cytokine production upon TLR triggering has been 
observed for human TLR1-9). Moreover, TLR mediated basophil responses can enhance 
the IgE mediated degranulation. These findings suggest that basophils may function as 
accessory cells skewing naïve T cells, in the presence of APCs, towards TH2 response 






1.3.4. Emergency myelopoieis   
Upon pathogen invasion, myeloid cells migrate to local tissues employing navigation 
capability of their chemokine receptors and are primed for phagocytosis as well as 
secretion of inflammatory cytokines, thereby playing key roles in innate immunity. 
 
Since myeloid cells represent the first line of defense against invading pathogens, there is 
no wonder that these cells are capable to rapidly mobilize from the BM upon acute 
infection. This process is commonly referred to as “emergency myelopoiesis”. 
Accompanied by increased proliferation and differentiation of HSPCs in the BM induced 
by infection, myelopoiesis becomes the predominant form of cellular production on 
expense of the production of lymphoid and erythroid cells (Takizawa et al. 2012). It is 
generally accepted, that HSCs and HSPCs are induced to proliferate and differentiate by 
two distinct mechanisms. First, mature cells are depleted form the BM as they 
differentiate and are released to the periphery thereby exerting a “pull” signal on HSCs 
and progenitors. The second “push” signal is generated by cytokines and colony 
stimulating factors produced by differentiated cells of hematopoietic (e.g. tissue 
macrophages) or nonhematopoietic (e.g. endothelial cells) origin triggered by infection 
(King and Goodell 2011). 
1.3.5. TLR mediated autophagy in myeloid cells 
Recently, the list of processes, leading to eventual elimination of infection, triggered by 
TLRs has been broadened to include the induction of autophagy (Sanjuan et al. 2007; 
Delgado et al. 2008; Shi and Kehrl 2008). Autophagy is an evolutionary conserved 
survival mechanism enabling the recycling of cytoplasmic components during starvation. 
This process involves the formation of double membrane organelles, called 
autophagosomes to sequester portions of the cytosol including long-lived proteins and 
damaged organelles. Autophagosomes then fuse with lysosomes do degrade their 
contents (Mizushima et al. 2002; Levine and Deretic 2007). 
 
Apart from its role in keeping cytoplasmic homeostasis during aging and development 
(Mizushima et al. 2002) the importance of autophagy in immunity becomes obvious 
(Levine and Deretic 2007; Lunemann and Munz 2008). Autophagy can not only 
contribute to intracellular pathogen elimination (Gutierrez et al. 2004; Nakagawa et al. 
2004) but also contribute to MHCII-restricted endogenous antigen presentation (Dengjel 
et al. 2005; Paludan et al. 2005), immune cell survival (Pua and He 2007; Miller et al. 
2008), TH1/TH2 polarization (Harris et al. 2007) and influence central tolerance (Nedjic 
et al. 2008). It has been shown that TLR (TLR3, TLR4, TLR7/8) triggering can induce 
autophagy in a mouse macrophage cell line RAW264.7. However, these studies suggested 
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that autophagy is largely a MyD88-independent process (Sanjuan et al. 2007; Xu et al. 
2007; Delgado et al. 2008).  
1.3.6. TLRs in immune disorders 
The initiation of emergency myelopoiesis is critically dependent on the recognition of 
pathogen that is achieved by pattern recognition receptors including TLRs (Takizawa et 
al. 2012). However the potent immune response triggered by TLRs represents a potential 
risk when induced inappropriately. Several studies have already emphasized the 
significance of tight control of TLR signaling and its breaks in disease pathogenesis.  
 
So far TLRs have been implicated in a plethora of inflammatory and autoimmune 
conditions including asthma, atherosclerosis, rheumatoid arthritis, multiple sclerosis, 
systemic lupus erythematosus and diabetes as well as tumor growth progression and 
metastasis (Pandey and Agrawal 2006; Kim et al. 2009). However, the evidence for the 
role of TLRs in development of some of these conditions is conflicting (Keogh and Parker 
2011). First TLR targeting drugs are currently undergoing pre-clinical or early-clinical 
phase evaluations and the upcoming results of these studies will provide insight in the 
potential of their therapeutical use. Nevertheless further research is needed to elucidate 




























2. Thesis Aims 
The main aims of the thesis were to 
(i) reveal the expression pattern of TLRs during murine early embryonic development 
(ii) identify the TLR expressing cells 
(iii) test whether TLRs are functional during embryonic development 
(iv) develop transgenic mouse models enabling the visualization and lineage tracing of 
cells with active Tlr2 promoter 
(v) identify differetially expressed proteins in detergent resistant microdomains of 
Francisella tularensis infected macrophages 































3.1. Flow cytometry and cell sorting  
Embryonic cell suspensions were prepared using dispase treatment. After Fc receptor 
blocking by rat anti-mouse CD16/32 antibody (2.4G2; Biolegend), single cell suspensions 
were stained with directly conjugated monoclonal antibodies. Fluorescence data were 
acquired using LSRII flow cytometer (BD Biosciences). Flow cytometry analyses were 
performed using FlowJo software (Tree Star). Cell debris and dead cells were excluded 
from the analysis based on scatter signals and Hoechst 33258 (Sigma-Aldrich) 
fluorescence. The intracellular staining procedure is described in section 4.4. Materials 
and Methods. Cell sorting was performed with the Influx cell sorter (BD Biosciences). 
3.2. Gene expression analysis 
Total RNA was isolated using the RNeasy Plus Micro Kit (Qiagen) and reverse transcribed 
using Premium RevertAid (Fermentas) and random hexamers (Fermentas). Quantitative 
RT-PCR (qRT-PCR) was performed using the LightCycler 480 SYBR Green I Master mix on 
a LigthCycler 480 (Roche). Each sample was tested in triplicate. The relative gene 
expression was calculated using LightCycler 480 1.5 software and normalized to a 
housekeeping gene mRNA level. Primers were designed using UPL software (Roche). 
Intron-spanning primers were used whenever possible. Primer efficiencies were 
calculated using LightCycler 480 1.5 software. Data were analyzed using Prism 5.03 
software (GraphPad). Microarrays were performed using MouseWG-6 v1 and MouseWG-
6 v2 Expression BeadChips (Illumina) as specified in section 4.3.  Materials and Methods. 
3.3. In vitro assays 
Following in vitro assays were used in this study:  
Differentiation of embryonic hematopoietic cells on OP-9 stroma (see section 4.1.3.6.) 
Proliferation of embryonic hematopoietic cells on OP-9 stroma (see section 4.1.3.6.) 
Colony forming cell assay (see section 4.1.3.7.) 
Phagocytosis assay (see section 4.3. Materials and Methods) 
Infection Assay: Synchronized Phagocytosis (see section 4.4. Materials and Methods) 
Cholesterol Depletion and Survival Test (see section 4.4. Materials and Methods) 
3.4. Cytokine antibody array, ELISA 
Changes in cytokine secretion were assessed using semiquantitative Mouse Cytokine 
Antibody Array G3 according to the manufacturer’s instructions (RayBiotech). Levels of 
TNF-α in supernatants were assessed using mouse TNFα ELISA Ready-SET-Go! kit 
(eBioscience). The serum levels of DEFA1-3 were measured using an ELISA kit (Hycult 




3.5. Determination of intracellular calcein-AM chelatable iron level 
Intracellular iron levels were measured using the fluorescent probe calcein-AM as 
specified in section 4.3. Materials and Methods.  
3.6. Immunohistochemistry and imaging 
Immunohistochemistry was performed as specified in section 4.1.3.8. Confocal 
microscopy images were acquired using Leica SP5 equipped with HCX PL APO 63.0 × 
1.40 Oil UV objective. Whole mount immunohistochemistry was performed as specified 
in section 4.1.3.8. Signals were visualized and digital images were obtained by using a 
Zeiss LSM 780 equipped with two photon, argon and helium–neon lasers. For 3D image, 
individual confocal planes (25-30 planes in 1-2 μm intervals) were projected to generate 
a single stacked 3D-reconstructed image using Imaris 7.3 (Bitplane). 
3.7. Quantitative image analyses 
Images were acquired with Olympus ScanR Screening Station for Life Science equipped 
with LUCPLFLN 20× PH objective. The data were analyzed by ScanR Analysis 1.3.0.3 
software (Olympus Imaging Solutions GmbH). Dead cells and debris were excluded from 
the analysis based on DAPI intensity value. 
3.8. BAC cloning  
(for details see section  4.2.2.) 
For cloning, restriction analyses, PCR verifying or transformation of electro-competent 
bacteria BAC DNA was isolated by alkaline lysis followed by phenol-chloroform 
extraction. Verified BACs were electroporated to EL250 bacteria equipped with the 
recombination machinery. The cassette was electroporated do BAC containing EL250 
bacteria and the recombination was induced by a heat shock. The neomycin cassette 
flanked by Frt sites was excluded by flipase. Upon validation performed by diagnostic 
restriction enzyme digest and sequencing, the BAC construct was electroporated to 
DH10B strain, and isolated by Qiagen® Large-Construct Kit. The quality of obtained BAC 
DNA was analyzed by Pulse Field Gel Electrophoresis and the sequence was validated by 
PCR followed by sequencing. BAC DNA was diluted to 1 ng/µl in injection buffer (10mM 
Tris HCl, pH 7.0, 100 μM EDTA) and the pronuclear injection (PNI) was carried out at the 
Transgenic Unit of IMG.  
3.9. Tamoxifen administration 
2 mg of tamoxifen (T5648, Sigma) was diluted in ethanol and sunflower oil and 
administered to pregnant dams by oral gavage. For details see section 4.2.2.) 
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3.10. Proteomic analyses 
SILAC labeling of J774.2 macrophages was performed as specified in section 4.4. 
Materials and Methods. Following SILAC labeling, DRMs were isolated as described in 
section 4.4. Materials and Methods. 2D Liquid Chromatography of triptic peptides was 
performed as described in section 4.4. Materials and Methods. The mass spectrometric 
analysis was performed on a 4800 MALDI TOF/ TOF Analyzer (AB Sciex) as described in 
section 4.4. Materials and Methods. Data acquisition and processing were carried out 
using 4000 Series Explorer software v3.5 (AB Sciex). Protein identification and 
quantification was conducted using ProteinPilot software v2.0.1 (AB Sciex) equipped 
with a Paragon searching algorithm, Pro Group algorithm (AB Sciex) and a PSPEP script 
that permits false discovery rate estimation as described in section 4.4. Materials and 
Methods. 
3.11. Small hairpin RNA (shRNA) treatment 
The J774.2 macrophages were spin-infected with p62-shRNA or control shRNA encoding 
lentiviral particles produced in HEK293T cells. 72 hours after lentiviral transduction, the 
J774.2 cells were either subjected to puromycin selection for 2 weeks or used directly for 
bacterial infection experiments. 
3.12. Western blot 
Samples were boiled in sample loading buffer for 10 min, loaded into 16% Tricine-SDS-
Urea-PAGE gel and run under reducing conditions (see section 4.5. of Materials and 
Methods).  Resolved proteins were transferred onto 0.2 µm PVDF membrane (Biorad), 
blocked in 3% BSA, incubated with specific Ab and detected with secondary anti-mouse 
HRP-labeled antibodies. GAPDH housekeeping protein was used as a loading control. The 
reaction was visualized by the West Dura ECL system (Pierce/Thermo Scientific). 
3.13. May-Grünwald-Giemsa (MGG) staining 
Sorted cells were stained according to MGG staining protocol (Penta). Leica DMI6000 
microscope was used for bright field imaging. 
3.14. Statistical analysis 
Statistical analyses were applied to the data and used statistical methods are indicated in 
each respective Figure or particular “Materials and Methods” section. Statistical analysis 







4. Results and Discussion  
4.1. Toll-like receptor 2 tracks the emergence of earliest erythro-
myeloid progenitors in precirculation embryo 
In this study we show that TLRs are expressed during early embryonic development. We 
determined that the source of TLR expression are maternal cells invading embryonic 
tissues as well as embryo-derived cells. We described a population of early 
postgastrulation embryonic hematopoietic progenitors that express TLR2 and posses a 
myelo-erythroid differentiation potential. TLR2 triggering enhanced the proliferation 
rate as well as myeloid differentiation of these hematopoietic precursors in a MyD88-
dependent manner. TLR2+ progenitors appeared in the embryo as early as at E6.5 and at 
E7.5 localized mainly to the extra-embryonic yolk sac.  We conclude that expression of 
TLR2 marks the emergence of common embryonic hematopoietic progenitors of early 
erythro-myeloid lineages and endows them with the capacity to boost the production of 
myeloid cells. 
 
The manuscript has been submitted to the Genes and Development journal and is 
currently in revision. 
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4.1.1.Abstract 
The discovery of mammalian Toll-like receptors (TLRs) unearthed the fundamental 
mechanisms that govern immunity to pathogens. Nevertheless, the biology of TLRs 
during embryonic development has been overlooked. Here, we show that all TLRs are 
expressed during early embryogenesis. Using a transgenic model to trace cells of 
embryonic origin, we provide evidence that hematopoietic precursors expressing TLR2 
preferentially differentiate into myeloid lineage cells in vivo and in vitro, and TLR2 
triggering enhances their proliferation rate as well as myeloid differentiation in MyD88-
dependent manner. In the presence of erythropoietin, TLR2+ precursors display the 
capacity to mature into primitive erythroid cells. The appearance of TLR2+ precursors in 
pre/early primitive streak embryo at E6.5 coincides with the onset of gastrulation, and 
these cells persist in both the yolk sac (YS) and the embryo proper before the 
establishment of circulation. However, only a subset of YS-derived TLR2+ckit+ 
progenitors coexpresses CD41, CD150 and Runx1, markers of primitive as well as 
definitive hematopoiesis. Taken together, the expression of TLR2 marks the emergence 
of common embryonic hematopoietic progenitors of early erythro-myeloid lineages and 








Despite extensive research, the understanding of the origin and developmental path of 
hematopoietic cells in an embryo is still incomplete (Ueno and Weissman 2007; 
Medvinsky et al. 2011). Conventionally, two main hematopoietic sites are considered in 
the developing embryo: the yolk sac and aorta gonad mesonephros region. The YS 
formation is at around E6.5-7.5 initiated by the association of extra-embryonic visceral 
endoderm and an inner layer of extra-embryonic mesoderm derived from the posterior 
primitive streak, which is formed shortly after the onset of gastrulation (E6.25-6.5) 
(Smith et al. 1994; Palis and Yoder 2001; McGrath and Palis 2005; Palis 2006). Later, cells 
ingressing from middle and anterior streak regions form an intra-embryonic mesoderm 
that gives rise to an additional hematopoietic site, the para-aortic splanchnopleura which 
later develops to the AGM (Tam and Beddington 1987; Kinder et al. 1999).  
 
The first hematopoietic cells emerge from the hemangioblast precursors in the forming 
YS around E7.25 (Moore and Metcalf 1970; Shalaby et al. 1997; Choi et al. 1998; Palis et 
al. 1999; Palis and Yoder 2001; Huber et al. 2004). It is believed that these differentiated 
cells, including primitive erythrocytes, macrophages and megakaryocytes, surrounded by 
a layer of endothelial cells and thus forming a cluster of cells called the blood island, 
provide only a transient and lineage-limited supply of hematopoietic progenitors (Palis 
et al. 1999; Xu et al. 2001). The first bona fide hematopoietic stem cells develop 
independently in AGM at around E10.5 (Muller et al. 1994; Dzierzak and Medvinsky 
1995; Medvinsky and Dzierzak 1996; Cumano et al. 2001). In addition, it has been 
recently shown that other developing hematopoietic tissues such as the chorion, 
allantois, placenta as well as vitelline and umbilical arteries can provide niche for an 
independent development of HSCs (de Bruijn et al. 2000; Zeigler et al. 2006; Rhodes et al. 
2008).  
 
The yolk sac is the first embryonic tissue where macrophages appear during early 
ontogenesis. However, due to a limited number of molecular and cellular markers, the 
original studies were unable to make any assertion of their differentiation pathway. 
Recently, three different myeloid cell populations have been shown to successively 
populate the mouse YS region. The first population is of maternal origin and displays a 
mature ckit– CD45+ phenotype, while the other two develop from ckit+ CD45– embryonic 
progenitors with macrophage and then erythro-myeloid differentiation potential 
(Bertrand et al. 2005b). Accumulated data also provided evidence that YS-derived 
myeloid precursors represent a specific lineage of cells capable of differentiating into 
adult tissue resident macrophages independently of HSCs (Alliot et al. 1999; Ginhoux et 
42 
 
al. 2010; Schulz et al. 2012). What remains uncertain is the nature of the immediate 
precursors of embryonic macrophage populations and their pathway of differentiation.  
 
Toll-like receptors (TLRs) recognize conserved microbial structures and are critically 
important for triggering immune responses to infections. In addition, the interaction of 
TLRs with their ligands also initiates several distinct signaling pathways that lead to the 
regulated development of antigen-specific immunity (reviewed in (Akira et al. 2001; 
Medzhitov 2007). Adult HSCs have been shown to express TLRs, allowing them to 
directly sense the presence of infections (Nagai et al. 2006; Sioud et al. 2006; De Luca et 
al. 2009). Notably, while TLR-independent BM hematopoiesis is driven by a combination 
of endogenous cytokines and growth factors (Ueda et al. 2005) , TLR stimulation can 
nudge this process towards increased production of myeloid cells (Nagai et al. 2006; 
Sioud et al. 2006; Boiko and Borghesi 2011). This serves as an important back-up 
mechanism when the rapid replenishment of short-lived myeloid cells is crucial for the 
maintenance of adult immune homeostasis (Holl and Kelsoe 2006; Welner and Kincade 
2007). So far, the biology of TLRs during early mammalian embryonic development has 
been overlooked and only a few studies have provided a limited set of data related to the 
expression levels of selected TLRs in developing murine placenta, lung, liver and brain 
starting from E10.0-13.0 (Harju et al. 2001; Kaul et al. 2012). Arguably, due to the 
absence of distinguishable developmental phenotype in all the murine TLR knockouts, it 
seems that their defects are solely immune related. Thus, whether TLRs are expressed 
and how can TLR signaling affect the development of hematopoietic lineages and/or their 
maturation in an early embryo (E6.5-10.5), was the main objective of this study. 
 
Here, we investigated not only the expression of TLRs in early embryonic hematopoietic 
precursors but also their capacity to employ TLR signaling to regulate embryonic 
hematopoiesis during an infectious assault. We demonstrated that a full complement of 
TLRs and their adaptor proteins are expressed during early embryogenesis. Using a 
transgenic model that allowed us to distinguish between cells of maternal and embryonic 
origin, we provided phenotypic and functional evidence that TLR2+ cells represent the 
earliest precursors of embryonic myelo- and erythropoiesis and that their engagement of 





4.1.3. Materials and Methods 
4.1.3.1. Mice 
CD1 and C57Bl/6J mice were maintained in the animal facility of the Institute of 
Molecular Genetics in Prague. pCAGEGFPMos3 mice expressing EGFP under the control 
of the β-actin promoter, here referred to as TgEGFP mice were obtained from Petr 
Svoboda (Nejepinska et al. 2012). MyD88–/– mice (B6.129P2(SJL)-Myd88tm1.1Defr/J), 
derived from MyD88fl mice (Hou et al. 2008), were obtained from The Jackson 
Laboratory. All experiments were approved by the ethical committee of the IMG. 
4.1.3.2. Cell suspension preparation 
Time pregnant females (the day that the vaginal plug was observed was designated as 
E0.5) were sacrificed by cervical dislocation and embryos from different stages of 
development were dissected from uteri. E6.5-8.5 embryos were carefully stripped of 
maternal decidua, Reichart’s membrane and the ectoplacental cone and were maintained 
intact, unless indicated otherwise. For FACS and mRNA analyses, cells from E7.5-E8.5 
dissected embryos were pooled from one litter. For the assessment of gene expression 
shown in Figure 1, later stage embryos, E9.5-12.5, were separated from extra-embryonic 
membranes (YS and amnion) and single embryos were analyzed. Due to their small size, 
for FACS analyses of E6.5 embryos, several litters were pooled. For cell sorting 
experiments, E6.5, 7.5, or E8.5 embryos from several litters were pooled as well. 
Embryos were washed in phosphate buffered saline (PBS) and dissociated using 1 mg/ml 
dispase (Invitrogen) in PBS for 10 min at 37 °C with occasional gentle pipetting. The 
reaction was stopped by the addition of 1% fetal calf serum (FCS) and a subsequent wash 
in 1% FCS in PBS. Embryonic suspensions were then passed through a 50μm cell strainer. 
4.1.3.3. Flow cytometry and cell sorting  
After Fc receptor blocking by rat anti mouse CD16/32 antibody (2.4G2; Biolegend) single 
cell suspensions were stained with the following directly conjugated monoclonal 
antibodies: anti-CD11b-PE (M1/70; eBioscience), anti-CD31-APC (MEC13.3; Biolegend), 
anti-CD41-APC (MWReg30; eBioscience), anti-CD45-PerCP (30-F11; BD PharMingen), 
anti-CD93- PECy7 (AA4.1; eBioscience), anti-CD144-A647 (VECD1; Biolegend), anti-
CD150-PECy7 (TC15-12F12.2; Biolegend), anti-B220-A647 (RA3-6B2; Biolegend), anti-
ckit-PE (ACK2; eBioscience), anti-F4/80-PECy7 (BM8; eBioscience), anti-Gr1-A647 (RB6-
8C5; Biolegend), anti-Ter119-PECy7 (TER-119; Biolegend), anti-Sca1-PerCP (D7; 
Biolegend) and anti-mouse Lineage Cocktail-Pacific Blue (Biolegend). Biotin conjugated 
anti-TLR2 antibody (6C2; eBioscience) was detected with streptavidin (SA)-APC or SA-
PECy7 (eBioscience). Fluorescence data were acquired using LSRII flow cytometer (BD 
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Biosciences). Flow cytometry analyses were performed using FlowJo software (Tree 
Star). Cell debris and dead cells were excluded from the analysis based on scatter signals 
and Hoechst 33258 (Sigma-Aldrich) fluorescence. Cell sorting was performed with the 
Influx cell sorter (BD Biosciences). 
4.1.3.4. Gene expression analysis 
Total RNA from whole embryos or sorted cells was isolated using a RNeasy Plus Micro Kit 
(Qiagen) and was reverse transcribed using Premium RevertAid (Fermentas) and 
random hexamers (Fermentas). Quantitative RT-PCR (qRT-PCR) was performed using 
the LightCycler 480 SYBR Green I Master mix on a LigthCycler 480 (Roche). Each sample 
was tested in triplicate. The relative amounts of mRNA were calculated using LightCycler 
480 1.5 software with Casc3 mRNA levels as the control. Primers were designed using 
UPL software (Roche). Intron-spanning primers were used whenever possible. Primer 
efficiencies were calculated using LightCycler 480 1.5 software. Primer sequences are 
listed in Table S1. Data were analyzed using Prism 5.03 software (GraphPad). The 
expression level of different TLRs and their adaptors highlighted in Figure 1 precluded 
the effect of primer efficiency factor. 
4.1.3.5. Tracking cells of maternal and embryonic origin 
To follow the cells of embryonic origin, we crossed the wild type (wt) CD1 females with 
heterozygous TgEGFP males. Only EGFP+ embryos were included in subsequent analysis. 
Due to paternal inheritance, all EGFP+ cells were considered to be of embryonic origin 
(Fig. S1A). To follow maternal cells, heterozygous TgEGFP females were crossed with wt 
CD1 males. Maternally derived EGFP-expressing cells were evaluated in wt embryos that 
did not inherit the maternal EGFP allele (~50%) (Fig. S1B).  
4.1.3.6. In vitro assays 
Distinct subpopulations of E6.5, E7.5 or E8.5 embryonic EGFP+ cells were sorted based on 
their TLR2, ckit and CD45 surface expression, plated on a semi-confluent layer of OP-9 
cells (gift from J.C. Zuniga-Pflucker) and cultured in RPMI containing 10% FCS (Sigma-
Aldrich). E6.5 and E7.5 sorted cells were supplemented with recombinant cytokines IL-3 
(1 ng/ml), SCF (50 ng/ml) GM-CSF (3 ng/ml) and M-CSF (10 ng/ml) (Biolegend). A 
thousand cells from each E8.5 sorted EGFP+ population were co-cultured with OP-9 cells 
in the presence or absence of Pam3CSK4 (Invivogen) for 72 hours. Total numbers of 
surviving EGFP+ cells were normalized to 10000 events obtained by FACS analysis. The 
proliferation history of EGFP+ TLR2+ cells was determined by the dilution of Cell 
Proliferation Dye eFluor 670 (eBioscience) according to manufacturer’s instructions. 
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4.1.3.7. Colony forming cell assay 
Sorted E7.5 cells were plated in methylcellulose medium M3434 (Stem Cell 
Technologies) according to manufacturer’s instructions. Cultures were maintained at 37 
°C in humidified air with 5% CO2. Hematopoietic colonies were counted at day 2-3 and 
harvested at day 10 for FACS analysis. Microscopic images were acquired using Nikon 
Diaphot 300 equipped with 10x/0.25 or Plan 20x/0.4 objectives. 
4.1.3.8. Whole mount embryo immunohistochemistry and imaging 
E7.5 embryos were dissected from decidua washed several times in ice cold PBS, fixed 
overnight in PHEM fixative (80 mM PIPES, 5 mM EGTA, 1 mM MgCl2, 25 mM HEPES at pH 
of 7.2, 3.7% formaldehyde, purified  0.1% Triton X-100) at 4°C and then rinsed three 
times in PBS.  Embryos were blocked in PBS supplemented with 10% of goat serum for 
1h. The primary antibody, purified rat anti-mouse TLR2 (clone 6C2, eBioscience) was 
added to a final concentration of 5 μg/ml for overnight at 4°C and developed with the 
secondary goat anti-rat IgG labeled with Alexa 488. The isotype control antibody 
produced no specific staining (data not shown). Embryos were then embedded with 
Vectashield mounting medium with 4‘,6-diamino-2-phentlindole (DAPI) (Vector 
Laboratories) and prepared for scanning. Signals were visualized and digital images were 
obtained by using a Zeiss LSM 780 equipped with two photon, argon and helium–neon 
lasers. For 3D images, individual confocal planes (25-30 planes in 1-2 μm intervals) were 



















4.1.4.1. Tlr and Tlr adaptor mRNAs are expressed in early stages of mouse 
embryonic development  
Twelve functional Tlrs and five Tlr adaptor proteins, namely MyD88, Mal, Trif, Tram and 
Sarm1, have been described in the mouse (Dunne and O'Neill 2003; Kawai and Akira 
2010). To obtain an overall picture of Tlr and Tlr adaptor protein expression during 
mouse early embryonic development from E7.5 to E12.5, we first determined their 
expression in whole embryos isolated as described in the Materials and Methods. We 
observed two distinguishable trends in the kinetics of expression patterns. Despite some 
subtle variations, Tlr1, Tlr4, Tlr5, Tlr6, Tlr11, Tlr12, Mal and Sarm1 expression showed a 
gradual increase during embryonic development, with Tlr1, Tlr6 and Mal expression 
slightly diminished at day E12.5 and Tlr11 displaying a unique pattern (Fig. 1A). In 
contrast, Tlr2, Tlr3, Tlr7, Tlr8, Tlr9, Tlr13, MyD88, Trif and Tram showed a convex-like 
expression profile, with a substantial decline at E9.5 (Fig. 1B). These data revealed 
expression profiles of genes postulated to play an essential role in innate immunity and 
suggested their involvement in immune and/or non-immune homeostatic processes 











































Figure 1. Tlr and Tlr adaptor mRNA expression during murine early embryonic development. 
Expression levels of Tlrs and Tlr adaptor proteins genes were quantified by qRT-PCR in isolated embryos 
in different stages of murine embryonic development (E7.5-E12.5). The observed signal was normalized 
to Casc3 mRNA levels. For each gene, the highest level of expression was set to an arbitrary value “1”. 
The kinetics of expression profiles of individual Tlrs and Tlr adaptor proteins were classified either as 
increasing (A) or convex (B). Error bars represent mean ± SD (n=3). 
 
 
4.1.4.2. Myeloid TLR2+ CD11b+ cells appear in the embryo before E10.5 
The early embryonic expression of Tlr genes strongly suggested that these receptors 
could be used to track the origin and developmental stages of embryonic hematopoiesis. 
Due to the commercial availability of specific antibodies, we analyzed surface expression 
of TLR2, along with other well-established hematopoietic and myeloid markers, at 
different stages of embryonic development. Notably, we detected the coexpression of 
CD11b on TLR2+ cells at as early as E7.5 (Fig. 2A). At this developmental time point, 
TLR2+ CD11b+ cells represented approximately 0.5% of total embryonic cells. Their 
frequency then dropped to 0.15-0.18% at E8.5-E9.5 and rose again to almost 1% at 
E10.5. Moreover, as illustrated in Figure 2, E7.5 TLR2+ cells were TLR2LOW CD11bHIGH and 
F4/80–/LOW, whereas E10.5 TLR2+ cells were predominantly TLR2HIGH CD11bLOW and 
F4/80+. We hypothesized that these changes in the cellularity and phenotype of TLR2+ 
cells reflected developmentally regulated processes that were associated with the rapid 





Figure 2. Early appearance of TLR2+ CD11b+ cells during mouse embryonic development.  
Embryos at different stages of development (E7.5-E10.5) were dissociated and single cell suspensions 
were stained for TLR2, CD11b, CD45 and F4/80 and analyzed by FACS. (A) Surface expression of TLR2 
and CD11b. Cell subsets with the low and high expression of CD11b are distinguished by separate gates. 





data from at least three independent experiments are shown.  
 
4.1.4.3. Maternal TLR2+ CD11b+ cells were replaced by embryonic TLR2+ CD11b+ 
cells during early embryonic development 
The differences in the level of TLR2, CD11b and F4/80 positivity prompted us to search 
for the source of TLR2+ cells in the embryo. We employed a transgenic mouse model 
suitable for the tracking of cells of maternal or embryonic origin (Fig. S1). These 
experiments revealed the existence of two different cell populations expressing the 
surface marker TLR2 at the early embryonic development (E7.5-8.5). As illustrated in 
Figure S1B, the first TLR2+ population represented maternal CD11bHIGH CD45+ cells that 
appeared early (E7.5), diminished gradually, and was barely detectable at E10.5. The 
other TLR2+ population was of embryonic origin and at E7.5 was devoid of hematopoietic 
markers such as CD45, CD11b (Fig. S1A). However, the expression of these markers 
gradually increased starting at E8.5. Together, these data demonstrated that the presence 
of maternal macrophages was of a transient nature and that at ~E8.5-9.5 these cells were 







4.1.4.4. Embryonic TLR2+ progenitor cells differentiated to TLR2+ CD45+ myeloid 
cells at E9.75-10.5 
The presence of TLR2 positive, but otherwise lineage negative (CD3–, Gr-1–, CD11b–, 
B220– and Ter119–) cells (Fig. S2) within E7.5 embryos suggested that this population 
could represent early progenitors that posses the potential for lineage commitment. 
Using an approach for tracking EGFP+ cells of embryonic origin (Fig. S1A), we gated on 
either TLR2+ or TLR2– cells (Fig. 3A) and analyzed their ckit and CD45 expression using a 
previously described labeling scheme (Bertrand et al. 2005b). As illustrated in Figure 3A, 
top panels, there were two phenotypically distinguishable stages during the specification 
of TLR2+ subset towards CD45+ hematopoietic lineage: (i) at E9.75, TLR2+ ckit+ CD45– 
cells acquired the surface expression of CD45, and (ii) the subsequent loss of ckit 
expression limited to the E9.75-10.5 time window of development. In this context, the 
prior accumulation of high levels of Cd45 mRNA at E7.5-9.5 strongly correlated with the 
capacity of these cells to undergo the developmental transition from TLR2+ ckit+ CD45– to 
TLR2+ ckit+ CD45+ subset (Fig. 3B). In contrast, a subset of TLR2– ckit+ cells, which 
remained CD45 negative between E7.5-10.5, failed to commit to the CD45+ hematopoietic 
developmental path (Fig. 3A, bottom right panels). These findings suggested that only 
TLR2+ ckit+ and not TLR2– ckit+ progenitor cells were endowed with the capacity to gain 
CD45 expression in vivo. 
 
The distinct developmental fate of the TLR2+ ckit+ and TLR2– ckit+ subsets correlated with 
their differential expression of relevant endothelial, hematopoietic and myeloid markers. 
To quantify these markers, we chose to look at embryonic cells isolated from E8.5, when 
the difference in Cd45 mRNA expression between TLR2+ and TLR2– subsets had reached 
its maximum (110 fold) (Fig. 3B). As the TLR2+ ckit+ CD45+ stage represented a 
developmental progression towards myeloid specification, the gene expression levels of 
this TLR2+ subset served as a positive control for myeloid markers. All expression levels 
were normalized to the TLR2– ckit– CD45– population. As illustrated in Figure 3C, TLR2+ 
ckit+ cells showed considerable expression of early endothelial/hematopoietic markers 
and transcription factors expressed in hemogenic endothelium (Flk1, Tie2, Cd31, Cd34, 
Cd41, Cd93, Cd105, Cd144, Cd150, Gata1, Gata2 and Lmo2), as well as myeloid markers 
(Csf1R, Cd11b, Mpo, Tlr4, Tlr9 and MyD88). As expected, during their maturation to the 
CD45+ stage, these cells tended to increase expression of myeloid markers while 
downregulating markers typically associated with transition from the hemangioblast to 
hemogenic endothelium and to early hematopoietic cells. Thus, due to its expression of 
both endothelial and hematopoietic markers (Huber et al. 2004) the TLR2+ ckit+ 
population could represent the hemogenic progenitor cells that, upon entry into the YS, 
display an early commitment to hematopoietic fate during normal mouse ontogeny.  
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Figure 3. Embryonic TLR2+ progenitor cells differentiate to TLR2+ CD45+ myeloid cells in vivo and in 
vitro. 
(A-F) Wt females were crossed with TgEGFP males to discriminate EGFP+ embryonic cells.  
(A) Live EGFP+ cells of either the TLR2+ or TLR2– phenotype isolated from the YS were analyzed for 
expression of ckit and CD45 during different stages of development (E7.5- E10.5) using FACS. (B) Cd45 












cells during different stages 
of development (E7.5-E10.5). Data are representative of 3-5 independent experiments (mean ± SEM). 
(C) mRNA expression of endothelial/hematopoietic progenitor- and macrophage-associated genes was 
analyzed in sorted E8.5 embryonic cells and normalized to the levels in the TLR2– ckit– CD45–  
population, which served as a negative control. Error bars represent mean ± SD (n=3). (D) E7.5 EGFP
+ 
TLR2+ ckit+ CD45– cells were sorted (two left panels), grown on OP-9 stromal cells in the presence of 
myeloid cytokine cocktail for 13 days and analyzed by FACS. (E, F) E7.5 TLR2+ ckit+ CD45– and E7.5 TLR2– 
ckit+ CD45– cells were sorted and plated in methylcellulose medium M3434 (Stem Cell Technologies) 
according to manufacturer’s instructions. (E) Hematopoietic colonies were counted at day 2-3 (left 
panel; 20x magnification; scale bar 50µm) and harvested at day 10 for FACS analysis (right panel; 10x 
magnification; scale bar 100µm). Microscopic images were acquired using Diaphot 300 equipped with 





4.1.4.5. TLR2+ ckit+ CD45– progenitors differentiated into TLR2+ ckit– CD45+ cells in 
vitro 
To directly follow the fate of TLR2+ ckit+ progenitors, their hematopoietic potential was 
assessed in vitro. Using crosses between wild-type females (CD1 strain) and TgEGFP 
males (Fig. S1A), we sorted TLR2+ ckit+ cells from E7.5 embryos (Fig. 3D, left panels) and 
cultured them on a monolayer of OP-9 stromal cells in the presence of a myeloid 
differentiation cocktail containing SCF, IL-3, M-CSF and GM-CSF. As illustrated in Figure 
3D, right panels, after 13 days the entire population of TLR2+ cells attained surface 
expression of CD45 and CD11b and gradually lost ckit expression. Approximately one 
third of the cells gained Gr-1 expression. In contrast, neither Ter119+ nor B220+ cells 
were detected. It is of note that neither the TLR2– ckit– CD45– nor the TLR2– ckit+ CD45– 
populations were able to survive or differentiate in this culture system, even when a 
higher number of sorted cells was plated (data not shown).   
 
However, the hematopoietic potential of E7.5 TLR2+ ckit+ embryonic hematopoietic 
progenitors was not restricted to the myeloid lineage. When these cells were plated for 
48-72 hours in methylcellulose colony assay supporting the growth of erythroid as well 
as myeloid colonies, the presence of small and compact colonies formed by relatively 
large cells that morphologically resembled those described previously as primitive 
erythroid cells (EryP-CFU; Erythroidprimitive-colony forming unit) (Ferkowicz et al. 2003) 
was microscopically detectable (Fig. 3E, left panel). Counting these colonies derived from 
sorted E7.5 TLR2+ ckit+ or TLR2– ckit+ cells demonstrated the enhanced erythroid 
potential of the former (Fig. 3E, right panel). When these cultures were inspected at day 
10, we observed absence of colonies in the plates seeded with TLR2– ckit+ cells, whereas 
plates seeded with TLR2+ ckit+ cells demonstrated the presence of relatively large 
colonies morphologically resembling CFU-GM (Granulocyte, Macrophage) and CFU-
GEMM (Granulocyte, Erythroid, Macrophage, Megakaryocyte) (Fig. 3F, left panel). As 
evident from FACS analysis shown in right panels in Figure 3F, the cells forming these 
colonies were (i) undergoing differentiation towards CD45+ ckit– stage; (ii) expressed the 
earliest marker of primitive erythroid and early macrophage progenitors, CD41; and 
contained a mixture of differentiated Ter119DIM CD45– cells (iii), as well as CD45+ CD11b+ 
myeloid cells (iv). This provided evidence that E7.5 TLR2+ ckit+ cells, in the presence of 
erythropoietin, possess the capacity to differentiate towards Ter119DIM CD45– primitive 
erythroblasts (Ferkowicz et al. 2003). On contrary, when adult BM cells were tested for 
erythro-myeloid differentiation potential on OP-9 stroma cultures, only Lin– TLR2– ckit+ 
progenitors displayed appreciable erythropoietic potential (Fig. S3). Together, the data 
presented in Figure 3, strongly support the view that E7.5 TLR2+ ckit+ cells represent 
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common hematopoietic progenitors that can produce CD45+ CD11b+ myeloid cells both in 
vivo and in vitro as well as primitive erythroid lineages. 
 
4.1.4.6. TLR2 stimulation promoted TLR2+ ckit+ precursor cell proliferation and 
myeloid differentiation  
The functional significance of TLR2 expression on ckit+ embryonic cells was assessed 
through stimulation with the TLR2 agonist Pam3CSK4. TLR2+ ckit+, TLR2– ckit+ and TLR2– 
ckit– cells were sorted from E8.5 EGFP+ embryos and co-cultured with the OP-9 stromal 
cells without cytokine or growth factor supplements in the presence or absence of 
Pam3CSK4 for 72 hours. As illustrated in Figure 4A and Figure S4A, the recovery of both 
TLR2– populations was ineffective whether stimulated with TLR2 agonist or not. In sharp 
contrast, approximately 24% (SD=11.5; n=3) and 39% (SD=8.6; n=3) of EGFP+ cells were 
recovered from cultures that were seeded with TLR2+ ckit+ embryonic precursors either 
unstimulated or stimulated with Pam3CSK4, respectively. The increased recovery rate 
observed upon TLR2 agonist treatment correlated with their higher rate of proliferation 
(Fig. 4B, middle panel; Fig. S4B, C). This effect was ameliorated in TLR2+ ckit+ progenitor 
cells derived from MyD88 deficient mice (Fig. 4B, right panel), formally demonstrating 
the involvement of TLR signaling in this process.  The quantification of this assay is 
presented in Figures S3B and S3C. Moreover, following 72 hours in culture, Pam3SCK4 
stimulated cells showed enhanced expression of the macrophage marker CD11b, 
suggesting a more efficient myeloid differentiation rate upon TLR2 stimulation (Fig. 4C). 
These data suggested that TLR2 engagement endowed embryonic hematopoietic cells 






































Figure 4. TLR2 stimulation enhances the proliferation and myeloid differentiation of E8.5 embryonic 
TLR2+ ckit+ CD45– cells.  
Wt females were crossed with TgEGFP males to identify EGFP+ embryonic-derived cells. E8.5 TLR2+ ckit+ 
CD45–, TLR2– ckit+ CD45– and TLR2– ckit– CD45– cells were sorted and plated on OP-9 stromal cells in the 
presence or absence of TLR2 agonist Pam3CSK4. After 72 hours of co-culture, cells were harvested and 
analyzed by FACS. Data are representative from three independent experiments. (A) Survival analysis of 
sorted TLR2– ckit+ CD45–, TLR2+ ckit+ CD45– and TLR2– ckit– CD45– cells either unstimulated or stimulated 
with Pam3CSK4 (1 μg/ml). (B) The proliferation history of TLR2+ ckit+ CD45– cells cultured in the 
presence or absence of Pam3CSK4 was assessed in MyD88+/+ (middle panel) and MyD88-/- mice (right 
panel) by the dilution of Cell Proliferation Dye eFlour® 670 in TLR2+ cells (left panel) as measured by 
FACS. See also Figure S4. (C) Surface expression of TLR2 and CD11b on cells derived from TLR2+ ckit+ 
CD45– cells grown on OP-9 cells in the presence or absence of Pam3CSK4 as determined by FACS. 
 
4.1.4.7. The presence of TLR2+ ckit+ CD45– hematopoietic progenitor at E6.5 
coincided with the onset of gastrulation  
Given the relative abundance of hematopoietic embryonic progenitor cells at E7.5, we 
assessed their presence during an earlier stage of development, before the formation of 
the blood island at E6.5. As illustrated in Figure 5A, ckit was coexpressed exclusively on a 
fraction of TLR2+ embryonic cells. The existence of an embryonic TLR2+ ckit– cell 
population suggested that TLR2 expression might precede the expression of ckit. This 
notion correlated with the data shown in Figure 3A (E7.5-E9.75, top panels), where 
apparently the majority of TLR2+ ckit– progenitors gradually acquired ckit expression 
before they become CD45 positive. Importantly, and as illustrated in Figure 5B, when 
E6.5 TLR2+ CD45– embryonic progenitors were FACS sorted and co-cultured for 10 days 
with OP-9 stroma in the presence of a myeloid differentiation cocktail, a sizeable fraction 
(>10%) of these cells differentiated to CD11b+ TLR2+ ckit– CD45+ myeloid cells. In 
contrast, the TLR2– CD45– population, gated as indicated in the left panel of Figure 5B, 
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was not able to survive or differentiate in this culture system (data not shown). Together, 
these data suggested that the initiation of embryonic myelopoiesis was concomitant with 
the onset of gastrulation, and the initial TLR2+ hematopoietic precursor cells were 















Figure 5. Myeloid cells differentiate from E6.5 TLR2+ cells in vitro.  
(A) E6.5 embryonic cells obtained from the crosses described in Figure S1A were analyzed for EGFP and 
TLR2 expression (left panel). Three distinct subsets were readily identified: two EGFP+ embryonic 
populations, either positive or negative for TLR2 expression, and the maternally derived EGFP– TLR2+ 
cells. Each of them was further analyzed for ckit and CD45 expression (three right panels). (B) E6.5 
TLR2+ CD45– cells were sorted (left panel), grown on OP-9 stromal cells in the presence of myeloid 
cytokine cocktail for 10 days and analyzed by FACS for indicated markers. Representative data from 
three independent experiments are shown. 
 
4.1.4.8. E7.5 TLR2+ ckit+ hematopoietic progenitors populated both extra- and 
intra- embryonic structures but displayed distinct phenotypes  
Next, we examined the spatial distribution of TLR2+ cells in the neural plate stage embryo 
(E7.5) using confocal microscopy.  As illustrated in Figure 6, TLR2+ cells occupied the 
space between the most proximal and the distal edge of the YS which approaches the 
embryo proper. In addition, detail examination of confocal as well as 3D-reconstructed 
images revealed the presence of TLR2LOW cells in the area from the level of the EP to the 
more proximal region of the YS (Fig. 6, white box, two right panels, and Movie S1). This is 
consistent with the expression of this marker on a small population of differentiating 
mesodermal cells migrating from the primitive streak into developing YS and their early 
commitment to hematopoietic fate. Importantly, it also correlates with the low 
expression TLR2 on E7.5 embryonic-derived hematopoietic precursors determined by 






Figure 6. TLR2+ cells localize mainly in the forming YS in E7.5 embryos.  
The whole mount embryos probed with anti-TLR2 (green) and DAPI (blue) revealed the presence of 
TLR2+ cells predominantly in the forming YS of the embryo. At this point of development, 90-95% of 
these cells were maternally-derived macrophages expressing higher levels of this antigen (Fig. 2).  
While some TLR2LOW progenitors of embryonic origin were also detectable in the YS structure, their 
exclusive presence in the region corresponding to the posterior primitive streak (PPS) (white box and its 
magnification in right panel) was consistent with TLR2 expression on the earliest hematopoietic 
progenitors migrating from this region into the developing YS. Signals were visualized and digital 




To validate these data by FACS analysis, we assessed the spatial distribution of TLR2+ 
ckit+ CD45– cells at E7.5, when the YS and embryo proper (EP) structures became 
separable (Fig. 7A). Single cell suspensions prepared from either the YS or EP were 
stained for TLR2 and ckit, and the numbers of EGFP+ TLR2+ ckit+ cells per embryo as well 
as their relative proportion to total cell mass were enumerated (Fig. 7B). These data 
confirmed that hematopoietic progenitors were not restricted to the YS, since EGFP+ 
TLR2+ ckit+ CD45– progenitors were readily detected in low but reproducible numbers in 
EP structures as well.  
 
Additional staining revealed that a large proportion of the YS-derived TLR2+ ckit+ 
progenitors were positive for the surface expression of one of the earliest markers of 
primitive and definitive hematopoiesis, CD41 (Integrin alpha 2b) (Mitjavila-Garcia et al. 
2002; Mikkola et al. 2003), as well as CD150 (SLAM), the marker of adult long term (LT)-
HSCs (Kiel et al. 2005) (Fig. 7C). Similarly, while expression of the endothelial marker 
CD31 (PECAM1) (Baumann et al. 2004) was also detectable on a fraction of TLR2– ckit+ 
CD45– cells, we observed approximately a 10-fold higher proportion of TLR2+ ckit+ CD45– 
CD31+ progenitors from the YS compared to EP (Fig. 7C and Fig. S5A). At E7.5 the surface 
expression of CD93 (AA4.1) (Petrenko et al. 1999) (Fig. 7C), Sca1 (Taoudi et al. 2005) 
(Fig. S5A) and CD144 (VE-cadherin) (Breier et al. 1996; Nishikawa et al. 1998) (Fig. S5) 





In addition, TLR2+ ckit+ cells isolated from YS, but not EP, were positive for mRNA coding 
for the transcription factor Runx1 which is required for blood cell specification (Fig. 7D). 
Similar levels of Runx1 were also expressed by the YS-derived TLR2– ckit+ population, a 
fraction of which was also positive for CD31, CD41 and CD150 (Fig. 7D). It is of note that 
a substantial difference observed in the expression of Runx1 between TLR2+ ckit+ cells 
isolated from separated YS and EP and the absence of TLR2+ CD41+ and TLR2+CD150+ 
cells in the separated EP (Fig. 7C) advocated for an insignificant level of cross-
contamination during the embryonic dissection. Together, our data presented in Figures 
6 and 7 strongly suggested that distinct cell environments could affect the differentiation 
and/or specification process of the TLR2+ ckit+ hematopoietic precursors prior to the 
establishment of embryonic circulation and that molecular processes underlying these 
events are initiated upon the migration of these cells to the YS environment which then 















































































Figure 7. The appearance of early hematopoietic markers CD41 and CD150 on E7.5 YS-derived TLR2
+
 
ckit+ cells, but not on those from the EP, correlates with Runx1 expression.  
(A-D) Wt females were crossed with TgEGFP males to identify EGFP+ embryonic cells. (A) The separation 
of E7.5 embryo into the embryo proper (EP) and the yolk sac (YS). (B) TLR2+ ckit+ CD45– cells were 
enriched in the YS compared to the EP. (C) Surface coexpression of TLR2 with CD31, CD41, CD150 and 
CD93 on the YS- and EP-derived ckit+ CD45– cells was determined by FACS. (D) Runx1 mRNA expression 
in sorted subsets of embryonic EGFP+ CD45– cells with combinatorial expression of ckit and TLR2 





Thus far, the expression and function of TLRs have been investigated almost exclusively 
in the context of adult immune cells. To the best of our knowledge, this is the first study 
where the spatio-temporal expression profile of TLRs in a post-gastrulation embryo has 
been evaluated on a cellular level. Specifically, we have demonstrated that, during 
embryonic development, TLR2 is expressed by an early-appearing transient population 
of maternal CD11b+ CD45+ macrophages, which at E9.5-E10.5 is replaced by newly 
generated embryonic cells of similar phenotype. This ontogenetically regulated 
phenomenon is also reflected by a drop in mRNA expression of several TLRs and their 
adaptor proteins (Tlr2, Tlr3, Tlr7, Tlr8, Tlr9, Tlr13, MyD88, Trif and Tram) around E8.5-
9.5. This finding is consistent with recent studies that suggest that an early embryo is 
colonized by sequential waves of maternally and then yolk sac-derived phagocytes 
(Bertrand et al. 2005b). Our data demonstrating the timely coordinated replacement of 
maternal phagocytes by embryonic phagocytes support the notion of their vital role in 
early embryonic developmental processes likely related to tissue remodeling and the 
secretion of trophic factors (Rae et al. 2007). 
 
We report here that, due to surface expression of TLR2, the first appearance of 
precursors of myeloid cells were traceable in the early streak embryo at E6.5. The 
hematopoietic commitment of E6.5-7.5 TLR2+ ckit+, but not TLR2– ckit+ cells, was marked 
by gradual transcript accumulation and at E9.5 by surface expression of CD45. We also 
determined that at E6.5 many TLR2+ cells coexpressed ckit and subsequently (E7.5-E8.5) 
started to express a set of molecular markers that are closely associated with the 
specification of the hemangioblast and its transition to the earliest hematopoietic 
progenitors. Notably, the coexpression of Flk1 with other relevant hematopoietic and 
endothelial markers on E8.5 TLR2+ ckit+ progenitors was consistent with the notion that 
Flk1+ hemangioblasts represent the earliest commitment towards the hematopoietic and 
endothelial lineages (Eichmann et al. 1997; Faloon et al. 2000; Huber et al. 2004; Lancrin 
et al. 2009). Our data also demonstrated that, between E9.5 and E10.5, the surface 
expression of TLR2 became largely restricted to CD45+ embryonic myeloid progenitors. 
Thus, the timing of the appearance of an embryonic TLR2 single positive population 
correlated with previously published data in which the presence of hematopoietic 
progenitors for both primitive erythroid and macrophage lineages was first detected in 
the yolk sac during the transition from the mid-streak stage at E7.0 to the neural plate 
stage at E7.5 (Palis et al. 1999). In this respect, TLR2 represents one of the earliest 
molecular signatures marking the specification of early embryonic hematopoietic 
precursors from nascent mesodermal cells shortly after their appearance at E6.25. These 
data imply that the onset of mammalian hematopoiesis is nearly concomitant with the 
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process of gastrulation (Smith et al. 1994; Kinder et al. 1999; Ferkowicz and Yoder 2005; 
Furuta et al. 2006).  
 
Moreover, and analogous to the situation in the adult bone marrow described by Nagai 
and colleagues (Nagai et al. 2006), the stimulation of E8.5 TLR2+ progenitors by 
Pam3CSK4 ligand enhanced their proliferation rate and differentiation to myeloid cells. 
As expected, this effect was not observed in progenitors derived from MyD88 deficient 
animals. However, as the proliferation and differentiation of TLR2+ embryonic 
progenitors proceeded at the basal level also without Pam3CSK4 stimulation, TLR2-
generated signals seemed dispensable for normal embryonic myelopoiesis under non-
inflammatory conditions. In agreement with our finding, no evidence for the impaired 
development of myeloid cells in TLR2 or MyD88 knockout mice has been reported 
(Adachi et al. 1998; Takeuchi et al. 1999). 
 
In the developmental context, TLR2 expression seems to endow cells with a 
predisposition to preferentially differentiate into myeloid cells. This notion fits well into 
the myeloid-based model of hematopoietic lineage restriction proposed by Kawamoto 
and colleagues. It posits that myeloid cells represent a prototype of hematopoietic cells 
and, as such, their myeloid developmental potential is retained during the early stages of 
branching out toward erythroid, T-cell, and B-cell lineages (Kawamoto and Katsura 
2009). The finding that TLR2 stimulation of early TLR2+ ckit+ CD45– precursors 
augmented their myeloid fate strongly supports this concept and demonstrates that (i) 
the mechanism of TLR driven hematopoiesis is operational not only in adults (Nagai et al. 
2006) but also in embryonic hematopoietic progenitors, and can thus be utilized 
continuously during the ontogenetic development as an evolutionary conserved 
“emergency” backup mechanism adopted for the rapid replenishment of circulating 
innate immune cells during infectious insult; and (ii) in this scenario, the expression of 
TLRs on hematopoietic precursors serves as a direct molecular link conveying microbial 
environmental cues to the genetically controlled myeloid-based differentiation program. 
 
Our data are consistent with the current paradigm positing that the first hematopoietic 
cells in the mouse embryo emerge from hemangioblast precursors that migrate from the 
posterior primitive streak to the forming YS around E7.25, where they give rise to 
differentiated cells including nucleated erythrocytes, macrophages and megakaryocytes 
(Moore and Metcalf 1970; Eichmann et al. 1997; Palis et al. 1999; Xu et al. 2001; Huber et 
al. 2004). However, while our data also demonstrated that E7.5 TLR2+ ckit+ CD45– 
hematopoietic progenitors reside mainly in the developing YS and only 5-10% of these 
cells can be found in the EP, only the former coexpress CD41, the marker indicative of a 
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commitment to early hematopoietic development (Ferkowicz et al. 2003; Mikkola et al. 
2003) and CD150, the marker of adult LT-HSCs (Kiel et al. 2005). Given the fact that only 
one third of mesodermal cells traversing the primitive streak emigrate to extraembryonic 
sites while the remaining cells colonize the EP and contribute to generate various 
derivates of intraembryonic mesoderm (Palis 2006), such phenotypic divergence 
between the YS- and EP-derived TLR2+ progenitors, caused either by their interaction 
with the environment in distinct regions of the embryo (Matsuoka et al. 2001; Nishikawa 
et al. 2001; Sugiyama et al. 2007) or, alternatively, by a regionalization of cell fates during 
their allocation along the anterioposterior axis (Tam and Beddington 1987; Kinder et al. 
1999; Ueno and Weissman 2010) suggests their separate developmental paths and most 
likely distinct contribution to embryonic hematopoiesis. Further experimentation is 
needed to resolve this issue. 
 
Importantly, the above described phenotypic distinction between the extra- and intra-
embryonic populations of E7.5 TLR2+ ckit+ cells is also paralleled by the expression 
profile of Runx1, a transcription factor that is essential for the primitive erythropoiesis as 
well as definitive hematopoiesis (Okuda et al. 1996; North et al. 1999; Lacaud et al. 2002; 
Yokomizo et al. 2008; Lancrin et al. 2009; Tanaka et al. 2012).  The expression of Runx1 
and CD41 in TLR2+ ckit+ early progenitors around E7.5 is also likely regulated by cues 
from within the YS environment, as these markers are absent in their TLR2+ ckit+ 
counterparts residing in the EP. This further strengthens the notion that the YS could act 
as an essential site for the initiation of primitive and definitive hematopoiesis (North et 
al. 1999; Lacaud et al. 2002; Ferkowicz et al. 2003; Li et al. 2006). 
 
Interestingly, recent genetic cell tracking experiments have demonstrated the essential 
contribution of E6.5-7.5 Runx1+ CD144+ YS-derived cells to the emergence of adult HSCs 
(Samokhvalov et al. 2007; Tanaka et al. 2012). Based on these data, it is tempting to 
speculate that definitive HSCs could also originate among these early TLR2+ 
hematopoietic ancestors. While further evaluation of this proposal is needed using a 
lineage tracing approach, the recently reported discovery of very slowly engrafting, adult 
CD150HIGH myeloid-biased HSCs whose full potential can be seen only after secondary 
transplantation supports this notion (Morita et al. 2010). Similarly, several studies have 
documented the occurrence of YS-derived adult myeloid cells independent of AGM origin 
(Alliot et al. 1999; Ginhoux et al. 2010; Schulz et al. 2012).  
 
In this study, we also documented the existence of a TLR2– YS population which is ckit+ 
CD41+ CD150+ and Runx1+, thus also fulfilling critical requirements for being considered 
a progenitor of hematopoiesis. However, because this thus far enigmatic population was 
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not able to survive and/or proliferate in the presence of OP-9 cells conditioned with 
either a myelo- or lympho-cytokine cocktail (Bertrand et al. 2005b; Tanaka et al. 2012) 
and did not express CD45 before E10.5, its hematopoietic potential remains uncertain.  
 
Taken together, our data illustrated the utility of TLR2 as a cellular marker of common 
embryonic precursors with an early commitment (E6.5) to primitive and definitive 
hematopoiesis and revealed a much broader complexity and dynamics of hematopoietic 
subpopulations at this stage of ontogenetic development. Herein, the described data also 
provided further evidence supporting the current paradigm that the YS serves as an 
important niche from where the mesodermal ancestors acquire the competence to 
initiate hematopoietic development.  
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4.1.7. Supporting Information  
 
Figure S1, Breeding schemes enabling tracking of embryonic and maternal cells, related to Figures 3-
5 and 7. 
(A) Tracking of embryonic cells. Wt females were crossed with heterozygous TgEGFP males expressing 
EGFP under the control of the β-actin promoter.  Only EGFP+ embryos were further analyzed. Based on 
EGFP expression, embryonic cells were discriminated from EGFP– maternal cells (white dots). EGFP 
positive heterozygous embryos (E7.5-E10.5) were analyzed for TLR2, CD11b and CD45 expression. The 




 embryonic cells.  
(B) Tracking of maternal cells. Heterozygous TgEGFP females expressing EGFP under the control of β-
actin promoter were crossed with wt males. Only wt embryos were further analyzed for the presence of 
EGFP+ maternal cells (green dots) transiently colonizing embryo at early developmental stages. Wt 
embryos (E7.5-E10.5) were analyzed for TLR2, CD11b and CD45 expression. The right side panels show 




 maternal cells. Representative data from at 







Figure S2, E7.5 TLR2+ ckit+ CD45– embryonic progenitors are lineage negative, related to Figure 3. 
E7.5 TLR2+ ckit+ CD45– embryonic cells were analyzed for the presence of lineage markers (CD3, Gr-1, 
CD11b, B220 and Ter119) by FACS. Live TLR2+ ckit+ CD45– cells were gated and their surface expression 
of lineage markers was compared to TLR2+ ckit– CD45+ maternal hematopoietic cells. Representative 























Figure S3. In the adult BM, the highest erythroid differentiation potential is found in the Lin– ckit+ 
TLR2– fraction, related to Figure 3. 
Adult BM cells were depleted for erythrocytes by ACK lysis. Differentiated progenitors and dead cells 
were excluded using lineage antibody cocktail and Hoechst 33258 viability dye respectively. Four 
populations of lineage– cells were sorted based on their ckit and TLR2 surface expression (A) and 
cultured on OP-9 stroma in the presence of a myelo-erythroid differentiation cocktail (SCF, IL-3, IL-6, 
EPO, M-CSF, GM-CSF). (B, C) After 3 days of co-culture the expression of Ter119 and CD45 was 















cells in vitro, related to Figure 4. 
(A) E8.5 TLR2+ ckit+ CD45–cells survive in culture with or without TLR2 stimulation 
E8.5 embryonic EGFP+ TLR2– ckit– CD45–, EGFP+ TLR2– ckit+ CD45– or EGFP+ TLR2+ ckit+ CD45– cells were 
plated on OP-9 cells and co-cultured in the presence or absence of Pam3CSK4 for 72 hours. Olympus 
CellR, magnification 20x, scale bar represents 100μm.  
(B, C) TLR2 triggered proliferation of E8.5 embryonic TLR2+ ckit+ CD45– cells is MyD88 dependent. 






cells derived from wt (MyD88
+/+
) or MyD88 
deficient (MyD88
– /–
) mice grown in the absence or presence of Pam3CSK4 for 72 hours measured by 
FACS. Live TLR2+ cells were included in the analysis. 
(C) Quantification of proliferation rate of E8.5 embryonic TLR2+ ckit+ CD45– cells derived from wt 
(MyD88
+/+
) or MyD88 deficient (MyD88
– /–
) mice.  
















Figure S5, Expression of hematopoietic and endothelial markers on early embryos, related to Figure 7 
(A-C) Wt females were crossed with TgEGFP males to discriminate EGFP
+
 embryonic cells. (A) 




cells isolated from 






cells were gated and the percentage of cells positive for TLR2 
and the indicated maker was enumerated (mean ± SD; n=3). 
(B, C) Surface expression of CD144 starts at E8.0 in the YS. Single cell suspensions isolated from the EP 
or YS portion of embryos at different stages of development (E7.5-E8.5) were analyzed for the surface 
expression of CD144. (B) The expression of ckit and CD144 on live embryonic (EGFP+) cells isolated from 
the EP (upper panel) and the YS (lower panel) respectively. (C) Coexpression of TLR2 and CD144 on 
EGFP+ ckit+ CD45– cells isolated from the EP (upper panel) and the YS (lower panel) respectively. 






Supplemental Movie S1, Anatomical location of TLR2+ cells in an early embryo, related to Figure 6.  
3D reconstructed image of E7.5 embryo stained with anti-TLR2 antibody (green) and counterstained 
with DAPI (blue) was generated by optical sectioning and projecting individual confocal planes (25-30 
planes in 1-2 µm intervals) using Imaris software 7.3 (Bitplane). 
 
 
Gene  Forward primer 5’– 3’ Reverse primer 5’– 3’ 
CasC3 TTCGAGGTGTGCCTAACCA GCTTAGCTCGACCACTCTGG 
Cd11b CAATAGCCAGCCTCAGTGC GAGCCCAGGGGAGAAGTG 
Cd31 GCTGGTGCTCTATGCAAGC ATGGATGCTGTTGATGGTGA 
Cd34 GGGTAGCTCTCTGCCTGATG TCCGTGGTAGCAGAAGTCAA 
Cd41 TGCTGCTGACCCTGCTAGT GTCGATTCCGCTTGAAGAAG 
Cd45 AGTAGGAAACTTGCTCCCCATCTGA TGGAGATCAGCTGTGCCCCT 
Cd93 GAGAATCAGTACAGCCCAACACCAG TGCCTATCCCAAGCCACCAGGT 
Cd105 CGTTCTCTTCCTGGATTTTCC ATTTTGCTTGGATGCCTGAA 
Cd144 GTTCAAGTTTGCCCTGAAGAA GTGATGTTGGCGGTGTTGT 
Cd150 GACCCCTGCACAACCATT TGTGGTGGGGTTTGGTTC 
Cd244 TTGTACCGTGTACGAGGAGGT CAAAGTTCTCCAGCTCTCTGC 
ckit GGAGCCCACAATAGATTGGTAT CACTGGTGAGACAGGAGTGG 
Csf1r CGAGGGAGACTCCAGCTACA GACTGGAGAAGCCACTGTCC 
Flk1 CCCCAAATTCCATTATGACAA CGGCTCTTTCGCTTACTGTT 
Gata1 TCCCAGTCCTTTCTTCTCTCC TCACACACTCTCTGGCCTCA 
Gata2 GCTTCACCCCTAAGCAGAGA TGGCACCACAGTTGACACA 
Lmo2 CGAAAGGAAGAGCCTGGAC CGGTCCCCTATGTTCTGCT 
Mal CTGCACTATGGCTTCATCCTC AGAGCCTGCCTGAACCAGT 
Mpo GGAAGGAGACCTAGAGGTTGG TAGCACAGGAAGGCCAATG 
MyD88 TGGCCTTGTTAGACCGTGA AAGTATTTCTGGCAGTCCTCCTC 
Runx1 CTCCGTGCTACCCACTCACT GCACTCTGGTCACCGTCAT 
Sarm1 GCTTGCTGGAGCAGATCCT TCACGCCTAGACCGATGC 
Tie2 GGCCAGGTACATAGGAGGAA CCCACTTCTGAGCTTCACATC 
Tlr1 GGCGAGCAGAGGCAATTGTGGA TTCTTCAGAGCATTGCCACATGGG 
Tlr2 GTTCATCTCTGGAGCATCCG ACTCCTGAGCAGAACAGCGT 
Tlr3 ATACAGGGATTGCACCCATA CCCCCAAAGGAGTACATTAGA 
Tlr4 GGACTCTGATCATGGCACTG CTGATCCATGCATTGGTAGGT 
Tlr5 ACGCACCACACTTCAGCA AGCCTCGGAAAAAGGCTATC 
Tlr6 GTCAGTGCTGGAAATAGAGC CCACGATGGGTTTTCTGTCT 
Tlr7 ACTCTCTTCTCCTCCACCAGACCT GAGGCCACTTGTCTGTCACACTG 
Tlr8 CAAACGTTTTACCTTCCTTTGTC ATGGAAGATGGCACTGGTTC 
Tlr9 CGCCCAGTTTGTCAGAGGGAGC GGTGCAGAGTCCTTCGACGGAG 
Tlr11 ATGGGGCTTTATCCCTTTTG AGATGTTATTGCCACTCAACCA 
Tlr12 TTTCAAGCACTGGCCTAACC GAAGCCTAGGCATGGCAGT 
Tlr13 CTATGTGCTAGGAGCTTCTGAGAG AGGAAGCAGAGAACCAGGAA 
Tram TGGTCAAGCAGTACCACTTCC GAGACGCCTTAGCCTCCAGT 
Trif ACCAGGGACCGGGAGATCTACCA CAAAGATGCTGGAGGGCGGCA 
 





4.2. Generation of Tlr2 reporter mice 
This chapter describes the process of generation of two transgenic reporter mouse 
strains suitable for visualization and fate mapping of cells with active Tlr2 promoter and 
their progeny. In addition, so far unpublished data, that confirmed that our attempt to 
generate Tlr2 reporter strains was successful, are included in this chapter to illustrate the 
benefits of the use of these transgenic mouse lines in hematopoiesis research. 
4.2.1. Introduction 
Since no unique surface marker of HSCs has been identified so far, the only way how to 
probe a cell to have HSC features is a successful reconstitution of adult irradiated host 
(Boisset and Robin 2012). However, probably due to lack of environmental cues and 
inability to express a proper set of homing receptors, these features posses only 
embryonic cells isolated after E10.5. Since TLR2+ precursors of appear way before E10.5, 
the only option to assess their differentiation potential in vivo and to reveal their full 
hematopoietic potential is the lineage tracing approach. For this purpose it was 
necessary to establish constitutive and inducible Tlr2 reporter mouse lines.  
 
In order to generate the transgenic mice we employed the Bacterial Artificial 
Chromosome (BAC) recombineering (recombination-mediated genetic engineering) 
strategy (Lee et al. 2001). Due to its simplicity and precisely defined methodological 
steps it allowed us to create transgenic mice in few months. BAC genomic clones often 
contain genomic segments that include most if not all of the extragenic cis-acting 
regulatory elements of a gene of interest. For this reason, BAC technology is suitable for 
generating transgenic mice because the relatively large insert size allows the expression 
of a gene under the control of its own regulatory elements, mimicking the endogenous 
expression pattern (Sharan et al. 2009).  
 
We have generated two mouse strains expressing constitutive and inducible Cyclic 
recombinase (Cre) under the control of Tlr2 promoter and its regulatory elements 
respectively. Cre is a tyrosine recombinase derived from the P1 bacteriophage that 
utilizes a topoisomerase I like mechanism to carry out site specific recombination events 
between two DNA recognition sites (loxP sites) (Hamilton and Abremski 1984). The 
bacteriophage uses Cre-lox recombination to circularize and facilitate replication of its 
genomic DNA when reproducing. Since being discovered, the bacteriophage's 
recombination strategy has been developed as a technology for genome manipulation in 
many organisms (Araki et al. 1997). The orientation and location of the genetically 
introduced loxP sites determine whether Cre recombination induces a deletion, 
inversion, or chromosomal translocation. If the loxP sites are oriented in the same 
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direction on a chromosome segment, Cre recombinase mediates a deletion of the loxP 
flanked (floxed) DNA segment. Typically, Cre and loxP mouse strains are developed 
separately and only thereafter crossed to produce a Cre-lox strain (Nagy 2000). The 
expression of Cre can be further controlled in inducible Cre strains that express a 
modified form of Cre that is non-functional until an inducing agent is administered at a 
desired time point in embryonic development or adult life. In the presence of synthetic 
ligand, the Cre fusion protein translocates into the nucleus where it exerts its function. 
 
In order to visualize cells with active Tlr2 locus, we decided to use Rosa26-YFP reporter 
strain, where EYFP is expressed from a very effective ubiquitous Rosa26 promoter after 
the floxed transcriptional termination sequence is removed by Cre recombinase (Srinivas 
et al. 2001). Upon recombination in F1 generation of these mice, EYFP is permanently 
expressed in all cells with active Tlr2 locus and their progeny (Figure 1). In addition to 
constitutive Tlr2-Cre mouse strain, we have generated Tlr2-CreERT2 strain, where the Cre 
recombinase is fused to a mutated ligand-binding domain of human estrogen receptor 
(ER) that lost its ability to bind endogenous estrogen, but binds tamoxifen. Due to this 
modification, CreERT2 protein, although constitutively expressed, is retained in the 




Figure 1. Diagram describing a model genetic experiment,where Tlr2-Cre and Rosa26-YFP mice are 





4.2.2. Materials and Methods  
4.2.2.1. Isolation of BAC DNA  
For cloning, restriction analyses, PCR verifying or transformation of electro-competent 
bacteria BAC DNA was isolated by alkaline lysis followed by phenol-chloroform 
extraction. BAC clones were grown in 50 ml LB media containing chloramphenicol     
(12.5 µg/ml) overnight (ON) in a shaker incubator at 37 °C (DH10B strain) or 32°C 
(EL250 strain) and 200 RPM. Bacterial pellets were lysed in 4 ml buffer P1 (50 mM Tris, 
pH 8.0, 10 mM EDTA, 100 mg/ml RNase A). Then, 4 ml of P2 buffer (200 mM NaOH, 1% 
SDS) was added, the tube was inverted two to three times to mix, and incubated for          
5 min. Finally, 4 ml of 2 M potassium acetate were added and the tube was inverted two 
to three times to mix. Upon chilling on ice for 15 min followed by centrifuging at 12,000 × 
g, the supernatant was transferred into a new tube and the phenol/chloroform 
extractions were carried out. Finally the BAC DNA was precipitated by adding an equal 
volume of isopropanol and chilling on ice for 15 minutes followed by centrifugation for 
30 min at 12,000 × g. The pellet was washed with 1 ml of 70% ethanol and centrifuged 
for 5 min at 3,000 × g. Upon air drying, the pellet was resuspended in 100 µl of water. For 
PNI BAC DNA was isolated using X-Large DNA isolation kit (Qiagen).  
4.2.2.2. Diagnostic restriction enzyme digestion of BAC clones 
Restriction enzymes that cut two to four times in the BAC sequence were selected and   
10 l of BAC DNA from mini-prep was digested with 0.5 l of enzyme, 2 l of 10× buffer, 
and 8 l of H2O at 37 °C for 1-4 hours. 
4.2.2.3. Polymerase chain reaction (PCR) 
For detection of endogenous Tlr2 in the BAC, following PCR reaction was set up: 
 
DNA    2 l 
10× Taq buffer   2.5 l  
25 mM MgCl2   2 l 
dNTP (10 mM each)  0.5 l 
primer Tlr2_i2-i3_F  1 l 
primer Tlr2_e2-300_R  1 l 
Taq (1 U/l)   1 l 






95 °C 5′ 00′′ 
[95 °C 0′ 30′′ 
57 °C 0′ 30′′ 
72 °C 1′ 20′′] 33x 





primer Tlr2_i2-i3_F  GCGTGATAATAATGATATGTC  
primer Tlr2_e3-300_R  CCAGAGAATAAAAGGCGTCTCC 
 
For cloning of homology arm in the Cre cassette following PCR reaction was set up: 
  
DNA     1 l 
5× Q5 buffer   5 l  
2.5 mM betain   10 l 
dNTP (10 mM each)  0.5 l 
primer F   0.5 l 
primer R   0.5 l 
Q5 polymerase (2 U/l) 0.25 l 


























98 °C 0′ 30′′ 
[98 °C 0′ 10′′ 
66 °C 0′ 30′′ 
72 °C 2′ 30′′] 30x 




For detection of recombined Cre allele and endogenous Tlr2 allele following PCR reaction 
was set up: 
 
DNA    2 l 
10× Taq buffer   2.5 l  
25 mM MgCl2   3 l 
dNTP (10 mM each)  0.5 l 
primer Tlr2_F   1 l 
primer Tlr2_R   1 l 
primer Cre_R   1 l 
Taq (1 U/l)   0.5 l 
H2O    13.5 l 
 
Primer sequences 
primer Tlr2_F  GAGACATCCTTGGTGAGCGT  
primer Tlr2_R  CCAGAGAATAAAAGGCGTCTCC 
primer Cre_R  TGCGAACCTCATCACTCGTT 
4.2.2.4. Transformation of electrocompetent bacteria (EL250) 
An isolated colony of EL250 bacteria was grown in 2 ml of LB/chloramphenicol (LB/CH) 
at 32°C ON. Next morning, 2 ml of starter culture was diluted in 100 ml of LB/CH and 
grown until it reached OD600=0.5-0.6. The cultures were than centrifuged for 5 min at 
3000 × g at 4°C. The pellet was then washed 2 times in 20 ml of ice cold H2O and 
resuspended in 100 µl of ice cold H2O. 3 µl of BAC DNA was mixed with 50 µl of bacteria 
and chilled on ice for 5 minutes. Upon transfer to a 0.2 cm cuvette, cells were 
electroporated (2.5 kV, 25 µF, 200 Ω). The transformed bacteria were transferred to 1 ml 
of LB and incubated at 32°C for 1 hour and then plated on a LB/CH plate and incubated 
for 20 hours at 32°C. 
4.2.2.5. Homologous recombination in bacteria 
EL250 bacteria containing the verified BAC clone were inoculated in 100 ml of LB/CH 
media and grown until the culture reached OD600=0.5-0.6. Then the cultures were split to 
two halves and each 50 ml of culture was incubated in inducing (42°C) or non-inducing 
(0°C) conditions for 15 minutes. Electrocompetent bacteria were prepared as described 
earlier. Induced and noniduced cell were transformed with 1.5 µl of Cre and Tlr2 
homologous arms containing cassette. Colonies generated from induced transformed 
cultures were PCR screened for the presence of the recombined allele. Positive colonies 
were used to inoculate 50 ml LB/CHK cultures for BAC DNA isolation. 
PCR program 
 
95 °C 5′ 00′′ 
[95 °C 0′ 30′′ 
57 °C 0′ 30′′ 
72 °C 1′ 20′′] 33x 




4.2.2.6. Exclusion of Neo cassette flanked by Frt sites 
Colonies of the recombinant strain containing the correct insertion of the transgene with 
its selectable marker (Neo/K) flanked by Frt sites were grown at 32°C overnight in 3 ml 
of LB/CHK. 1 ml of the culture was diluted into 10 ml of LB/CHK and grown at 32°C until 
it reached an OD600=0.6. Then, 100 µl of 10% filter-sterilized arabinose were added to a 
final concentration of 0.1% to induce the flp gene in EL250 strain. The culture was grown 
at 32°C for 1 hour and 100 µl of 10–3 and 10–4 dilutions were plated on LB/CH and 
LB/CHK plates and incubated at 32°C ON to reveal the efficiency of Neo cassette 
exclusion. The clones that lost the selectable marker by site-specific recombination were 
screened for antibiotic sensitivity by simultaneous plating on LB/CH and LB/CHK plates. 
The loss of Neo cassette was further validated by PCR.  
4.2.2.7. Preparation of BAC DNA for pronuclear injection 
Upon validation by diagnostic restriction enzyme digest and sequencing, the BAC 
construct was electoporated to DH10B strain, again validated and a large scale culture 
was set up for BAC DNA isolation using the Qiagen® Large-Construct Kit. The quality of 
obtained BAC DNA was analyzed by Pulse Field Gel Electrophoresis (PFGE) in 1% 
agarose gel (6 kV/cm, 120 °, 16 hours, 14°C) and the sequence was validated by PCR 
followed by sequencing. BAC DNA was diluted to 1 ng/µl in injection buffer (10mM Tris 
HCl, pH 7.0, 100 μM EDTA) and the pronuclear injection (PNI) was carried out at the 
Transgenic Unit of IMG.  
4.2.2.8. Cell suspension preparation 
Time pregnant females (the day that the vaginal plug was observed was designated as 
E0.5) were sacrificed by cervical dislocation and embryos from different stages of 
development were dissected from uteri. For FACS analysis, cells from E7.5-E8.5 dissected 
embryos were pooled from one litter. Embryos were washed in phosphate buffered 
saline (PBS) and dissociated using 1 mg/ml dispase (Invitrogen) in PBS for 10 min at 
37°C with occasional gentle pipetting. Dispase was removed from cell suspensions by 
centrifugation of the cells followed by washing of the cells with 1% FCS in PBS.  
Embryonic suspensions were then passed through a 50 μm cell strainer. 
4.2.2.9. Flow cytometry and cell sorting  
After Fc receptor blocking by rat anti mouse CD16/32 antibody (2.4G2; Biolegend) single 
cell suspensions were stained with the following directly conjugated monoclonal 
antibodies: anti-CD11b-PE (M1/70; eBioscience), anti-CD45-PerCP or anti-CD45-A450 
(30-F11; BD PharMingen), anti-B220-A647 (RA3-6B2; Biolegend), anti-ckit-PE (ACK2; 
eBioscience), anti-Ter119-PECy7 (TER-119; Biolegend). Biotin conjugated anti-TLR2 
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antibody (6C2; eBioscience) was detected with streptavidin (SA)-APC, SA-PECy7 or SA-
Qdot605 (eBioscience). Fluorescence data were acquired using LSRII flow cytometer (BD 
Biosciences). Flow cytometry analyses were performed using FlowJo software (Tree 
Star). When possible, cell debris and dead cells were excluded from the analysis based on 
scatter signals and Hoechst 33258 (Sigma-Aldrich) fluorescence.  
4.2.2.10. Tamoxifen administration 
Tamoxifen solution was prepared as follows, for one dose, 2 mg of tamoxifen (T5648, 
Sigma) was resuspended in 80 μl ethanol and further dissolved in 320 μl sunflower oil 
(S5007, Sigma). This 1 mg/100 μl tamoxifen solution was shaken rigorously at 55°C. 200 
μl of tamoxifen solution (1 mg/100 μl) was administered to time pregnant ROSA-YFP 



























4.2.3.1. Generation of Tlr2 Cre reporter mice  
The workflow of this procedure is depicted in Figure 2. First step in this approach was 
the selection of BAC clones carrying the entire Tlr2 gene and its regulatory elements from 
publically available repository (Children's Hospital Oakland Research Institute; CHORI, 
USA). A 180kb long BAC clone encompassing Tlr2 gene with extensive upstream (46 kb) 
and downstream (123 kb) sequences (RP23-455F23) was obtained from BAC resource 
depository at CHORI. 
 
Figure 2. Diagram describing the process of generation of a BAC reporter, adopted from (Fu and 
Maye 2011). 
 
Upon BAC clone verification (PCR, diagnostic restriction enzyme digest), the generation 
of recombinant construct with a selected type of reporter gene followed. To insert the 
reporter gene in the sequence of Tlr2, homology arms located a few nucleotides 
upstream of Tlr2 gene translation start site and 3’downstream sequence were PCR-
cloned into the reporter cassette Cre-FRT-Neo-FRT (gift from Dr. Kozmik) and CreERT2-
FRT-Neo-FRT (gift from Dr. Kořínek) respectively (Figure 3). 
 
 
Figure 3. The schematic illustration of Tlr2-Cre and Tlr2-CreERT2 construct generation.  
Cre and CreERT2 replaced the fist and only coding exon (exon3) of Tlr2 gene respectively.  
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This enabled its homology recombination in a bacterial strain where the gene 
recombination event was heat induced (strain EL250). Subsequently the selection 
marker (neomycin resistance (Neo), flanked with Frt sites), included in the cloning 
cassette, was removed by flipase (flp) the expression of which was induced by the 
addition of arabinose. The resulting transgenic BAC was then isolated and its integrity 
and quality verified (PCR, diagnostic restriction enzyme digest, sequencing, pulse field 
gel electrophoresis) before the pronuclear injection (PNI) (Sharan et al. 2009). The PNI 
(Figure 4) was carried out by the Transgenic Unit of the IMG, headed by Dr. Sedláček. In 
case of Tlr2-Cre construct, 3 PCR positive founders were found among 39 born mice and 
the transgene was transmitted to F1 progeny from 2 out of 3 founders. In case of Tlr2-
CreERT2 construct, also 3 PCR positive founders were identified among 24 pups obtained. 
The Tlr2-CreERT2 transgene was transmitted to F1 progeny from two of these founders, 
the third founder being sterile. All founders were backcrossed to C57Bl/6N background. 
 




Figure 4. Generation of Tlr2 Cre recombinase constructs. 
(A) The presence of Tlr2 gene in BAC RP23-45523 was verified by PCR. (B) To insert Cre recombinase in 
the sequence of Tlr2, homology arms located a few nucleotides upstream of Tlr2 gene translation start 
site and 3’downstream sequence were PCR-cloned into reporter cassettes CreERT2-FRT-Neo-FRT and 
Cre-FRT-Neo-FRT respectively. This enabled its homology recombination in a bacterial strain where the 
gene recombination event was heat induced (strain EL250). (C, D) The resulting transgenic BAC was 
then isolated and its integrity and quality verified by pulse field gel electrophoresis and PCR before the 







4.2.3.2. Visualization of TLR2 expression in Tlr2-Cre reporter strain  
One of the crucial questions concerning the ontogenesis of hematopoietic system is 
whether HSCs or their progenitors originate from the EP or the YS. To visualize emerging 
cells with active Tlr2 locus, we crossed the Tlr2-Cre males, where Cre recombinase is 
expressed under the control of Tlr2 promoter and its regulatory elements, with Rosa26-
YFP females (Srinivas et al. 2001). As a result, EYFP (hereafter referred to as YFP) 
fluorescence was detected in the cells where recombination occurred as well as in all 
their progeny (Figure 5).  
 
 
Figure 5. Visualization of cells with active Tlr2 locus using Tlr2-Cre mouse strain. 
In Tlr2-Cre mice the Cre recombinase is expressed under the control of Tlr2 promoter. Upon breeding of 
Tlr2-Cre mouse with Rosa26-YFP mouse, Cre excises a transcription terminator preceeding EYFP flanked 














Indeed YFP positive cells were detectable as early as at E7.5 (Figure 6). At E7.5 most of 
the YFP+ cells were localized to the YS–EP boundary, close to the posterior primitive 
streak region. At E8.75, YFP+ cells showed a more disperse pattern, however a significant 
number of these cells localized to the head/brain region. In the context of previously 
published data describing that microglia derive from YS myeloid precursors and appear 
in the brain at E9.5 (Ginhoux et al. 2010), the head/brain localization of YFP+ cells 
suggests that these cell could represent microglia precursors. 
 
 
Figure 6. Visualization of cells with active Tlr2 promoter during embryogenesis. 
Rosa26-YFP females were crossed to Tlr2-Cre males. YFP fluorescence in E7.5 and E8.75  F1 embryos 
was detected using Olympus SZX9 (zoom 6.3-57.0 x) fluorescence stereomicroscope (two left panels) or 
Nikon AZC1 confocal macroscope (two right panels). The magnification of middle left panel is shown in 
middle right panel. Scale bar represents 200 μm.  
 
FACS analysis of E7.5-E8.5 YFP positive cells revealed that only less than 1% of them co-
expressed TLR2 on their surface. Interestingly, most of YFP+ cells expressed the 
prototypical progenitor marker, c-kit. In addition to c-kit, most of E8.5 YFP+ cells 
coepressed the erythroid lineage marker Ter119 (Figure 7A). In the peripheral blood of 
adult animals all three main hematopoietic lineages (erythroid, myeloid and lymphoid) 
were identified in the pool of YFP+ cells with minor contribution to the erythroid lineage, 
suggesting the involvement of Tlr2 promoter region activation in uncommitted 
hematopoietic precursors (Figure 7B). In peripheral blood of adult animals, YFP+ cells 
represented 11.6% (SD=4.9 n=3) of all viable cells and the majority of them coexpressed 
TLR2 on their surface (mean = 82.9%, SD= 6.2, n=3). The highest level of TLR2 surface 
expression was detected in the pool of CD11b+ myeloid cells, whereas lymphoid cells 
showed only low TLR2 expression (data not shown). Interestingly, when the distribution 
of individual hematopoietic lineages was compared in YFP+ and YFP– cells from the same 
sample, it appeared that in the pool of YFP+ cells, erythroid cells were much less 
abundant than CD45+ cells. Additionally, while myeloid cells were significantly enriched 
in the YFP+ fraction as compared to YFP– cells, no difference was found in the proportion 
of lymphoid cells (Figure 7C). These data suggest that the commitment of cells with 








Figure 7. Phenotypic analysis of YFP+ cells derived fromF1 progeny of ROSA26-YFP mice crossed with 
Tlr2-Cre mice . 
Rosa26-YFP females were crossed to Tlr2-Cre males. The phenotype of YFP+ cells isolated from (A) E8.5 
embryos or (B) peripheral blood of F1 adult mice was determined by FACS. The histogram shows 
surface expression of TLR2 in YFP
+
 cells (open green histogram) and YFP
–
 cells (open violet histogram) 
as compared to the signal derived from secondary reagent only (closed grey histogram). In double color 









) cells were calculated based on FACS data. 
Percentage of Ter119+ and CD45+ cells among all live cells is shown in left panel, percentage of CD11b+, 







 cells is shown in right panel. p values were calculated using two tailed 
paired t-test; * pval ≤ 0.05, (*)pval ≤ 0.1. 
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4.2.3.3. TLR2 lineage tracing using Tlr2-CreERT2 reporter strain 
To track the developmental fate of embryonic TLR2+ cells, Tlr2-CreERT2 males were 
crossed with Rosa26-YFP females and the recombination in F1 progeny was induced by 
tamoxifen administration to pregnant dams by oral gavage at specific time points. In 
these experiments, YFP was expressed only in cells which at the time of induction 
attained active Tlr2 promoter and transcribed the Tlr2-CreERT2 construct. This enabled 
genetic labeling (YFP expression) of cells with active Tlr2 locus into a narrowly defined 
time-window of early embryonic development. Importantly, since all progenies of these 
cells retained YFP expression throughout entire lifespan, their lineage identity could be 





Figure 8. Lineage tracing of cells with active Tlr2 locus using Tlr2-CreER
T2
 mouse strain. 
In Tlr2-CreER
T2
 mice the inactive Cre recombinase is expressed under the control of Tlr2 promoter. Upon 
breeding of Tlr2- CreERT2 mouse with Rosa26-YFP mouse, the modified Cre is expressed in cells with 
active Tlr2 promoter and is retained in cytoplasm untill tamoxifen is administered. Only upon tamoxifen 
binding CreERT2 translocates to the nucleus and removes a transcription terminator preceeding EYFP 








In a pilot experiment, to test the efficiency of the inducible model, we crossed a Rosa26-
YFP female with a Tlr2-CreERT2 male, induced the recombination in the pregnant dam by 
5 mg of tamoxifen at E10.5 and assayed the recombination efficiency in the E12.5 fetal 
liver (Figure 9). 48 hours after tamoxifen treatment, 0.2% of E12.5 FL cells expressed 
YFP and thus represented the recombined cells. Additionally, more than 50% of YFP+ 
cells coexpressed TLR2 on their surface. In the pool of YFP+ cells we have identified 




Figure 9. Tamoxifen induced Tlr2-dependent cell  tagging at E10.5 analyzed after 48 hours.  
Rosa26-YFP female was crossed with Tlr2-CreER
T2
 male. Tamoxifen was administered in a single dose (5 
mg) at E10.5 to the pregnant dam by oral gavage. After 48 hours, embryos were harvested and fetal 
livers (FL) analyzed for the presence of YFP
+
 cells. The histogram shows surface expression of TLR2 in 
YFP
+
 cells (open green histogram) and YFP
–
 cells (open violet histogram) as compared to the signal 
derived from secondary reagent only (closed grey histogram). In double color dotplots, TLR2
+
 cells are 
highlighted in red color.  
 
When recombination was induced at E9.5 and embryos were analyzed at E16.5, we 
detected all main hematopoietic lineages (erythroid, myeloid and B-lymphoid) in the 
pool of YFP+ cells isolated from the FL (Figure 10). In contrast to the cells isolated from 
the FL, YFP+ cells found in peripheral tissues represented mainly differentiated CD45+ 





Figure 10. Tamoxifen induced Tlr2-dependent cell tagging at E9.5 marks all main hematopoietic 
lineages in E16.5 fetal liver. 
Rosa26-YFP female was crossed with Tlr2-CreERT2 male. Tamoxifen was administered in a single dose (2 
mg) at E9.5 to the pregnant dam by oral gavage. At E16.5 embryos were harvested and fetal livers 





 embryos. Scale bar 200 μm). (B) The histogram shows surface 
expression of TLR2 in YFP
+
 cells (open green histogram) and YFP
–
 cells (open violet histogram) as 
compared to the signal derived from secondary reagent only (closed grey histogram). (C) FACS analysis 
of expression of differentiation markers c-kit, CD45, Ter119, CD11b and B220 in E16.5 YFP
+
 cells isolated 





Interestingly, induction of recombination at E6.75 resulted in similar amount of YFP 
labeled cells in the E16.5 FL. YFP+ cells in the FL represented mainly TLR2– erythroid 
cells and TLR2+ myeloid cells. In the E16.5 fetal thymus, YFP marked, apart from very few 
erythroid, myeloid and B-lymphoid cells, almost exclusively CD8+CD4+ thymocytes that 
should appear in the fetal thymus after E16.0 (Figure 11) (Zuniga-Pflucker and Lenardo 
1996). These data suggest that early post-gastrulation cells with active Tlr2 regulatory 





Figure 11. Tamoxifen induced Tlr2-dependent cell tagging at E6.75 marks all main hematopoietic 
lineages in E16.5 fetal liver and T cells in the fetal thymus. 
Rosa26-YFP female was crossed with Tlr2-CreERT2 male. Tamoxifen was administered in a single dose (2 
mg) at E6.75 to the pregnant dam. E16.5 embryos were harvested and fetal livers (FL, A) and thymi (FT, 
B) analyzed for the presence of YFP+ cells. The surface expression of TLR2 as well as all main 
hematopoietic differentiation markers was analyzed in YFP
+
 cells. The histogram shows surface 
expression of TLR2 in YFP
+
 cells (open green histogram) and YFP
–
 cells (open violet histogram) as 
compared to the signal derived from secondary reagent only (closed grey histogram). In double color 
dotplots, TLR2
+




The generation of inducible TLR2 reporter mouse strain represents a unique and so far 
the only effective tool to reveal whether TLR2 expressing cells posses the potential to 
develop into bona fide HSCs and which developmental path they choose to follow. In 
addition the development of a mouse line expressing Cre recombinase under the control 
of endogenous promoter enabled us to visualize all cells with active Tlr2 locus, including 
progenitors which have not yet started or just started to express TLR2. The selection of 
BAC recombineering as a method of choice enabled us a rapid development of two 
transgenic mouse strains. It took only 2 months for the first transgenic animals to be 
born since BAC stub receiving. The implementation of this method in our laboratory 
allowed us to widen the scope of our research. Moreover the Cre recombinase system 
enables specific Tlr2-promoter driven deletion of a number of genes upon breeding with 
transgenic mice where the gene of interest is flanked by lox P sites. Thus important 
transcription factors involved in early hematopoietic commitment like Runx1 can be 
specifically deleted in the progeny of Tlr2-Cre mice bred with Runx1tm3.1Spe mice 
available from The Jackson Laboratory (Bar Harbor, ME, USA). 
 
Using the constitutive Tlr2-Cre strain we were able to localize emerging recombined cells 
with active Tlr2 locus to the E7.5 EP and EP-YS boundary. It is of note, that in three 
independent experiments performed so far at E7.5, YFP+ cells were detected only in one 
litter and YFP was expressed only in one embryo out of three Tlr-Cre PCR positive 
embryos. These data suggest that E7.5 could be the earliest time point for detection of 
recombined cells and thus YFP fluorescence might not be detected at this time point.  The 
one day delay in appearance of these cells in comparison to TLR2+ cells detected at E6.5 
embryo by FACS, likely reflects the time needed for the production of active Cre 
recombinase followed by rearrangement of STOP cassette, YFP synthesis and folding. 
Such a delay in YFP expression has been previously observed in another study with 
similar setup and was further prolonged when inducible Cre was used (Yona et al. 2013). 
 
While E7.5-E8.5 YFP+ cells represented mainly erythroid cells and c-kit+ hematopoietic 
precursors, the progeny of these cells repopulated all main hematopoietic lineages in the 
adult peripheral blood (erythroid, myeloid and lymphoid). These data revealed an 
unexpected involvement of Tlr2 locus activation in hematopoietic lineages that either 
don’t express or express very low levels of surface TLR2 (erythroid and lymphoid cells). 
However, when proportions of distinct hematopoietic lineages were compared in YFP+ 
and YFP– cells in the adult blood, myeloid cells clearly dominated the pool of YFP+ cells 
upon endogenous Tlr2 dependent recombination. In addition, myeloid YFP+ cells 
expressed the highest levels of surface TLR2. Together these data confirmed our in vitro 
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data which suggest that hematopoietic progenitors with an active Tlr2 locus exhibited 
enhanced myeloid differentiation.   
 
Lineage tracing experiments performed with the inducible Tlr2-CreERT2 strain revealed 
that cells with active Tlr2 regulatory elements contribute to all hematopoietic lineages 
and hence suggest their importance at the onset of hematopoiesis. When Cre 
recombination was induced in early post-gastrulation embryos at E6.75, YFP+ cells were 
traced not only in E16.5 FL erythroid and myeloid lineages but also in double positive 
fetal thymocytes. This finding points to the enormous plasticity of early post-gastrulation 
hematopoietic progenitors. While additional experiments, such as the engraftment of 
E6.5 induced hematopoietic progenitors in adult irradiated host, are required to bring 
more information on this issue, our data provide the very first evidence that early 
hematopoietic progenitors with an active Tlr2 locus can contribute to the pool of 
hematopoietic stem cells. Alternatively, cells with an active Tlr2 locus could overlap with 
lymphomyeloid-restricted progenitors undergoing extensive lymphoid transcription 
priming in the E9.5 YS, before the emergence of definitive HSCs and establishment of FL 
hematopoiesis (Yoshimoto et al. 2012; Böiers et al. 2013). While the lymphoid priming of 
these HSC-independent progenitors was so far back-traced to E9.5 (Böiers et al. 2013), 
our data suggest that progenitors at ~ E7.5, irrespective of their localization, could be 
already committed to this fate.  
 
What remains to be determined is the kinetics of embryonic hematopoietic and 
peripheral tissues colonization of Tlr2-tagged cells starting at E6.5 and their single cell 

















4.3. Toll-like receptors expressed on embryonic macrophages couple 
inflammatory signals to iron metabolism during early ontogenesis.  
 
In this study we have, for the very first time, shown that a full spectrum of Toll like 
receptors is expressed in E10.5 embryonic macrophages. We have also demonstrated 
that TLRs on the surface of E10.5 macrophages are fully functional and respond to 
triggering by production of inflammatory cytokines in a MyD88- and Trif-dependent 
manner. Using a comparative mRNA microarray, we have determined differences in the 
expression pattern between E10.5 embryonic macrophages and adult peritoneal 
macrophages as well as embryonic non-macrophage cells. Based on our original data and 
their comparison with recent results published by Schulz at al. (Schulz et al. 2012), we 
have concluded, that the general transcription profile of Tlrs and their adaptors (with few 
exceptions) in all macrophage populations analyzed is largely independent of their 
origin, location and developmental stage and thus is common for all myeloid cells tested. 
We have also shown that E10.5 embryonic macrophages are equipped with protein 
machinery essential for iron recycling. Additionally, iron metabolism in embryonic 

















































4.4. Quantitative Proteomics Analysis of Macrophage Rafts Reveals 
Induction of Autophagy Pathway at the Early Time of Francisella 
tularensis LVS infection. 
In this study we provided evidence that infection of macrophages with F. tularensis leads 
to changes in protein composition of detergent-resistant membranes (DRMs). Using 
SILAC-based quantitative proteomic approach, we observed the recruitment of 
autophagic adaptor protein p62 to DRMs at early stages of microbe−host cell interaction. 
Using confocal microscopy, we visualized the colocalization of p62 with ubiquitinated, 
LC3 decorated, intracellular F. tularensis microbes peaking at 1 h postinfection. 
Furthermore, F. tularensis infection of p62-knockdown macrophages led to a transient 
increase in the intracellular number of microbes up to 4 h after in vitro infection. While 
there no direct evidence for it yet, we propose, that TLR2 triggering could activate 
autophagy to inhibit the bacterial growth as described by Sanjuan et al. (Sanjuan et al. 
2007). 
 
Together, our data suggested that the activation of autophagy pathway in F. tularensis 
infected macrophages, which impacts the early phase of microbial proliferation, is 
subsequently circumvented by ongoing infection. 
 




































4.5. Eosinophils from patients with type 1 diabetes mellitus express 
high level of myeloid α-defensins and myeloperoxidase.  
In this study we have described enhanced expression of myeloid α-defensins in capillary 
blood of type 1 diabetic (T1D) patients. We have identified eosinophils as the source of 
myeloid α-defensin expression. Based on myeloid α-defensin mRNA expression we could 
distinguish two groups of patients, defensin-high-diabetics (DHD) and defensin-normal-
diabetics (DND). Eosinophils of DHD patients expressed 200x higher levels of DEFA1-3 
mRNA and contained significantly higher amount DEFA1-3 protein as measured by 
intracellular FACS than eosinophils isolated from healthy donors. We have demonstrated 
that myeloid α-defensins could serve as a reliable molecular signature of eosinophil 
cellular activation. Our results demonstrated the presence of transcriptionally active 
eosinophils in patients with T1D and argue for the involvement of innate immunity at the 
onset of T1D. While our findings did not provide the elucidation of the mechanism of 
eosinophil activation in patients with T1D, based on published data, we hypothesized 
that eosinophil activation could be a direct consequence of bacterial or viral infections. 
Our speculative model envisions a plausible involvement of eosinophils in the 
pathogenesis of T1D through their TLR-mediated activation and subsequent 
degranulation. This way, cytotoxic proteins released from eosinophil primary granules 
could cause severe tissue damage and in turn, initiate immune presentation of 
autoantigens linked to the pathogenic process of self-destruction. In this scenario, α-
defensin expression in eosinophils could serve as a molecular readout of the progression 
of diabetogenic process. Moreover, we believe that this study will promote heightened 
interest of research community in the involvement of eosinophils in the onset of 
autoimmune-related diseases in general. 
 




























5. General Discussion  
In mammals, Toll like receptors have been most frequently associated with evolutionary 
conserved immune responses elicited by innate immune cells, especially, myeloid cells 
(Muzio et al. 2000; Hornung et al. 2002). TLRs represent a set of germline encoded 
pattern recognition receptors recognizing a diverse spectrum of pathogen-associated 
molecular patterns and probably also detect endogenous stress signals through danger-
associated molecular patterns. Their prominent role has been recognized in the induction 
of innate immune responses, indispensable for rapid elimination of pathogens. In 
addition to their essential role in the first line of defense against infectious agents 
(Medzhitov 2001), they are critical in triggering adaptive immune responses that 
ultimately lead to the antigen-tailored immune response with a long-lasting memory 
(Akira et al. 2001).  
 
Recently, TLRs have been discovered to be expressed on HSCs and HSPCs, where they can 
sense pathogens and drive their proliferation and differentiation along the myeloid 
lineage (reviewed in (Yanez et al. 2013)). While it was believed, that there is no 
phenotype alteration in hematopoiesis of TLR deficient mice, some recent findings 
suggest that the absence of TLR4, TLR9 or the TLR adapter protein MyD88 but not TLR2 
gives HSCs an advantage in transplantation assays. This observation argues that HSCs 
could be vulnerable to certain TLR ligands during handling or in the damaged 
environment of irradiated recipients (Ichii et al. 2010).  Thus, in addition to the response 
to “pull” and “push” signals delivered by their environment, HSCs might be able to 
directly respond upon ligation of their TLRs. However, the significance of this proposition 
has been recently challenged by a study showing that LPS-induced emergency 
myelopoiesis depends on TLR4-expressing nonhematopoietic cells (Boettcher et al. 
2012). Undoubtedly, more studies are needed to resolve this issue. 
 
So far, all studies investigating the role of TLR expression and function in HSPCs were 
conducted on adult hematopoietic cells. We have, for the first time, shown that TLR2 is 
expressed on hematopoietic precursor cells of embryonic origin. TLR2 triggering 
enhances the proliferation rate as well as differentiation of embryonic hematopoietic 
progenitors towards myeloid lineage in MyD88-dependent manner. Using in vitro and in 
vivo Tlr2 lineage tracing experiments we have shown that very early embryonic 
hematopoietic precursors with active Tlr2 locus could differentiate to all hematopoietic 
lineages and give rise to adult type hematopoietic cells. The very early emergence of 
these progenitors opens the question concerning the YS versus intra-embryonic origin of 
HSC precursors. Based on our preliminary results with constitutive Tlr2-Cre reporter 
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strain we cannot rule out, that hematopoietic precursors originate in the embryo proper 
from early mesodermal cells. Further, we suggest that the presence of TLRs on these 
progenitors could be in agreement with a proposed myeloid based model of 
hematopoietic cells differentiation. This model posits that myeloid differentiation 
potential is retained in all, erythroid, T and B lineage branches (Kawamoto et al. 2010). In 
this scenario, the myeloid program starts to operate very early in the development in 
TLR2+ progenitors and is retained in either HSCs that originate from these cells or in 
embryonic progenitors with mixed myelo-lymphoid potential (Böiers et al. 2013). Taking 
in account that the population of embryonic c-kit+ TLR2+ cells might be quite 
heterogeneous, additional assays analyzing the expression pattern on single cell level 
could address this question.  
 
Apart from the hematopoietic precursors, the whole spectrum of TLRs is expressed in 
E10.5 YS-derived macrophages. While the expression of PRRs during early 
embryogenesis has not been described previously, we have also shown that TLRs 
expressed by E10.5 YS-derived macrophages are fully functional. There is no doubt that, 
during embryogenesis, a substantial pool of tissue resident macrophages originates 
either from YS or AGM/FL macrophages (Ginhoux et al. 2010; Schulz et al. 2012; Yona et 
al. 2013). An elegant study by Ginhoux and colleagues has shown that microglia derive 
from YS myeloid progenitors that arise before E8.0, seed the brain through circulation 
before the blood-brain barrier closes and postnataly are maintained independently of 
circulating adult monocytes (Ginhoux et al. 2010). Interestingly, a study aiming to reveal 
the transcriptional regulatory pathways underlining the identity and diversity of tissue 
macrophages concluded that macrophage populations from different organs are 
considerably diverse (Gautier et al. 2012).  When we compared expression profiles of 
E10.5 TLR2+ embryonic and adult TLR2+ peritoneal macrophages with publically 
available microarray data, derived from E10.5 YS and E16.5 tissue macrophages supplied 
by Schulz and colleagues, we observed the gene clustering of E10.5 TLR2+ macrophages 
with  E10.5 YS-derived F4/80+ and E16.5 F4/80BRIGHT tissue macrophages. This 
relationship was even further strengthened when differentially expressed genes from 
E10.5 TLR2+ cells were compared across these three populations. On contrary, analysis of 
TLRs and their adaptor proteins revealed no obvious clustering of any of the macrophage 
populations tested (Schulz et al. 2012). This suggests that TLR expression cannot 
distinguish between diverse macrophage populations. Rather, this uniform pattern of 
TLR expression shared by all macrophage subsets seems to represent the functional 
signature of prototypic myeloid program which operates in these cells. Interestingly, our 
RNA microarray analysis identified many differentially overexpressed genes in E10.5 
TLR2+ embryonic macrophages as compared to adult TLR2+ peritoneal macrophages and 
119 
 
E10.5 TLR2‒ cells. Among them four transmembrane proteins were prominent; Cx3cr1, 
Mrc1, Stab1 and Fpn1. While all of these proteins were described to play a role in adult 
tissue resident macrophages, it was rather surprising, that they were enriched in the 
embryonic YS-derived macrophages as compared to tissue resident peritoneal 
macrophages (Kzhyshkowska et al. 2006; Wentworth et al. 2010; Gautier et al. 2012). 
Particularly, the sole mammalian iron exporter, ferroportin (Fpn1), attracted our 
attention. Fpn1 is highly expressed on duodenal enterocytes, placenta, hepatocytes and 
tissue resident macrophages and enables the absorption of maternal and dietary iron. 
Apart from the materno-fetal transfer that establishes initial iron stores, the 
macrophage-mediated recycling of iron is probably the most potent way how to supply 
enough iron for erythroid precursors (Donovan et al. 2005; Recalcati et al. 2012). As a 
consequence, the expression of Fpn1 is tightly controlled on multiple levels. Ferroportin 
expression is negatively regulated by inflammatory mediators (Yang et al. 2002), 
particularly the acute phase protein hepcidin, that binds Fpn1 and mediates its 
internalization and degradation. Additionally, expression of Fpn1 is also regulated post-
transriptionally by the iron regulatory protein system (IRP) (Wallander et al. 2006). Our 
results have shown, that in embryonic macrophages, expression of Fpn1 coupled with 
iron flow can be directly downregulated upon TLR2 signalling in a MyD88-dependent 
manner, leading to iron sequestration in M1 polarized inflammatory macrophages. 
Moreover the expression of Fpn1 on the surface of embryonic macrophages could attest 
for their role in intraembryonic iron recycling upon phagocytosis of erythroid cells. This 
is, in addition to Fpn1-mediated iron transport from visceral endoderm, which was, until 
now, considered as the only source of embryonic iron. Together, our data described a 
novel way to activate the prototypic M2-like embryonic macrophages towards the 
inflammatory M1-phenotype associated with the pro-inflammatory cytokine and 
chemokine expression and iron sequestration.  
 
Next, we focused on pathogen-host interaction of intracellular bacteria Francisella 
tularensis with macrophages as their primary target. Due to its extreme virulence, ease of 
aerosol transmission and lethality, F. tularensis has been recognized as a potentially 
deadly biological weapon (Dennis et al. 2001; Tarnvik and Berglund 2003). The 
prerequisite for the pathogenicity of F. tularensis is its ability to invade and replicate in 
host cells, mostly phagocytes (Hall et al. 2008). Upon infection, macrophages engulf F. 
tularensis, and although the destiny of the phagosome is to fuse with lysosomes, F. 
tularensis escapes to the cytosol, where it can proliferate (Santic et al. 2008). Importantly, 
strains that fail to avoid the phago-lysosomal fusion and or cannot escape to the cytosol 
are attenuated in their virulence (Lindgren et al. 2004). Recently, cholesterol-rich 
detergent resistant microdomains (DRM) have been shown to be essential for the entry 
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of F. tularensis to macrophages (Tamilselvam and Daefler 2008). We confirmed that F. 
tularensis requires intact cholesterol-rich DRMs to enter J774.2 macrophage cell line. 
Therefore, we aimed to elucidate the early stages of interactions of macrophages with the 
bacteria by determining the protein composition of DRMs upon F. tularensis infection 
using a quantitative mass spectrometry based proteomic approach. Only one protein, 
Sequestosome 1 (Sqstm1/ p62), was found to be specifically recruited to DRMs upon F. 
tularensis internalization with significant reproducibility. This cytoplasmic multimodule 
adaptor protein contains an ubiquitin binding domain as well as a segment that interacts 
with autophagosomal transmembrane protein LC3. Thus p62 can directly bridge 
degradation of polyubiqutinated protein aggregates with the process of autophagy (Seto 
et al. 2013). Indeed we have observed very early colocalization of ingested bacteria 
covered with ubiquitinated proteins with LC3+ autophagosomes peaking at 1 hour post 
infection. While Checroun and colleagues, who focused on later stages of infection, 
described autophagy induction 24 hours upon F. tularensis infection, our data are in 
agreement with observations of Chiu and colleagues describing the antibacterial effect of 
a small autophagy inducing molecule AR-12 at 2.5 and 24 hours postinfection. Moreover, 
p62 silencing led to increased bacterial load during early, but not late phases of infection 
(Checroun et al. 2006; Chiu et al. 2009). However, the initiation of autophagy pathway, 
necessary for F. tularensis elimination, is still enigmatic. Autophagy, an ancient cellular 
homeostatic process that is also involved in multiple immune pathways, including 
intracellular pathogen removal, endogenous antigen presentation, modulation of 
TH1/TH2 polarization and shaping of central tolerance, and they all can be induced also 
by TLR triggering (Nakagawa et al. 2004; Paludan et al. 2005; Harris et al. 2007; Sanjuan 
et al. 2007; Nedjic et al. 2008; Delgado and Deretic 2009). It has been shown, that a 
particle that engages TLRs on the surface of macrophages, while it is phagocytosed, 
guides the autophagosome marker LC3 to phagosomes using the autophagy-dependent 
pathway. This LC3 translocation is associated with phagosome fusion with lysosomes, 
leading to a rapid acidification followed by enhanced pathogen killing. Similarly to TLR2-
induced autophagy, described by Sanjuan and colleagues, we could not observe the 
formation of double membrane vacuoles around ingested F. tularensis 1 hour post 
infection, when the interaction of p62 with LC3 peaked (Sanjuan et al. 2007). In 
summary, our study revealed for the first time, F. tularensis-driven, very early activation 







Finally, in the last study included to this thesis, we investigated the role of myeloid cells 
in type 1 diabetes (T1D) which is an autoimmune disease caused by immune-mediated 
destruction of insulin producing pancreatic β-cells leading to insulin deficiency and 
persistent hyperglycemia. Even with the current insulin substitution therapy, secondary 
complications such as blindness, heart disease or kidney failure may develop in T1D 
patients. A whole spectrum of immune cells has been associated with T1D onset or 
progression. Both CD4+ and CD8+ T lymphocytes have been implicated as key players in 
β-cells destruction, while other cells as DCs, macrophages, B cells and NK cells have 
regulatory roles. Myeloid cells including DCs and MFs participate in auto-antigen 
presentation to T cells and their priming; at the onset of the disease, insulin specific CD4+ 
T cells appear, later on, T cells specific for other pancreas specific antigens dominate. 
Pancreatic β-cells lack MHC class II proteins, suggesting that direct cell destruction can 
only be mediated by CD8+ cytotoxic T cells that recognize peptide antigen: MHC class I 
complexes displayed on β-cells (Katz et al. 1993; Bulek et al. 2012). Apart from direct 
cell-to-cell contact, cytotoxic T cells can mediate elimination of β-cells by releasing of 
pro-inflammatory cytokines, granzyme B, or perforin, and possibly by signaling through 
pathways of programmed cell death (Khadra et al. 2011). Regulatory T cells might be 
involved in protection from T1D, since the decrease in their numbers promotes a more 
severe disease while their adoptive transfer leads to the opposite outcome (Salomon et 
al. 2000; Tonkin and Haskins 2009). B cells, although not directly pathogenic to β-cells, 
can participate in disease progression by production of autoantibodies followed by 
generation of immune complexes, and possibly by antigen presentation to generate 
primary autoreactive T cell responses, maintenance of CD4+ T cell memory or production 
of pro-inflammatory cytokines (Cox and Silveira 2009). Accumulation of NK cells, DCs, 
macrophages or eosinophils in earliest islet infiltrates attests for their so far enigmatic 
role in T1D development (Hessner et al. 2004; Kim and Lee 2009; Brauner et al. 2010).  
 
However, the research of the regulatory immune networks in human T1D is complicated 
by limited access to appropriate samples due to ethical and practical concerns (Han et al. 
2012). Thus, in our study we focused on analysis of readily accessible peripheral 
capillary blood samples. Interestingly we detected increased level of myeloid α-defensins 
in approximately 30% of T1D patients (defensin high diabetic, DHD). The analysis of cell 
populations in peripheral blood of DHD patients identified eosinophils as the exclusive 
source of myeloid α-defensins. This was a surprising finding considering that under 
physiological conditions, neutrophils are the main source of myeloid α-defensins 
(Borregaard et al. 2007). Additionally, myeloid α-defensins were elevated in eosinophils 
isolated from the peripheral capillary blood of defensin-normal-diabetic (DND) patients 
with normal level of myeloid α-defensins in total blood samples. Thus, transcriptional 
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activation of eosinophils manifested by increased expression of myeloid α-defensins and 
myeloperoxidase could represent a general process linked to the pathology of T1D. The 
level of myeloid α-defensins expression in peripheral capillary blood eosinophils could 
serve as a diagnostic marker of the disease progression. In support of our data, 
eosinophil infiltration in pancreas and pancreatic lymph nodes has been previously 
associated with development of diabetes in the model of BioBreeding rat (Hessner et al. 
2004). 
 
The role of the innate immune system in triggering T1D was shown only recently. 
Research in this area was greatly facilitated by the discovery of Toll-like receptors (TLRs) 
that were found to be crucial for induction of effective immune response. The number of 
studies, although sometimes with contradictory findings, associating TLRs and diabetes 
induction is steadily growing (Kim et al. 2007; Zipris 2010; Li et al. 2012a; Gülden et al. 
2013; Lee 2013).  For example, apoptotic β-cells cells undergoing secondary necrosis 
stimulated the priming of diabetogenic T cells through a TLR2-dependent, but TLR4-
independent, activation of antigen presenting cells and the development of autoimmune 
diabetes was markedly inhibited in Tlr2‒/‒ mice but not in Tlr4‒/‒ mice (Kim et al. 2007). 
We hypothesize, that eosinophils could be involved in the development of autoimmune 
diabetes through their TLR-driven activation and subsequent degranulation related to 





















6. Conclusions  
This thesis is based on three original articles, one submitted manuscript and unpublished 
data that contribute to our knowledge about the role of myeloid cells in embryonic 
development and disease. In addition, the presented thesis is supported by one 
methodologically related published article and one submitted manuscript. The results 
can be summed up as follows: 
 
Toll like receptors and their adaptor proteins are expressed during embryogenesis.  
Apart from maternal myeloid cells and differentiated YS-derived phagocytes emerging 
around E9.5, TLRs are expressed on early hematopoietic progenitors. Hematopoietic 
precursors expressing TLR2 preferentially differentiate into myeloid lineage cells in vivo 
and in vitro, and TLR2 triggering enhances their proliferation rate as well as myeloid 
differentiation in a MyD88-dependent manner. In the presence of erythropoietin, TLR2+ 
precursors display the capacity to mature into primitive erythroid cells. The appearance 
of TLR2+ precursors in pre/early primitive streak embryo at E6.5 coincides with the 
onset of gastrulation, and these cells persist in both the yolk sac and the embryo proper 
before the establishment of circulation. However, only a subset of YS-derived TLR2+ ckit+ 
progenitors coexpresses CD41, CD150 and Runx1, markers of primitive as well as 
definitive hematopoiesis. Taken together, the expression of TLR2 marks the emergence 
of common embryonic hematopoietic progenitors of early erythro-myeloid lineages and 
endows them with the capacity to boost the production of myeloid cells.   
 
Using BAC recombineering, we generated two transgenic Tlr2 reporter mouse strains 
suitable for visualization and lineage tracing of cells with active Tlr2 locus. We have 
shown that the Tlr2 promoter is activated during early postgastrulation embryonic 
development in hematopoietic precursor cells that give rise to all lineages of adult type 
hematopoiesis.  
 
E10.5 CD45+ CD11b+ F4/80+ macrophages coexpress Toll-like receptors (TLRs) and 
CD14. These embryonic YS derived myeloid cell have the capability to engulf both 
apoptotic cells and bacteria, secrete upon TLR stimulation a broad spectrum of pro-
inflammatory cytokines and chemokines, proving that these receptors are fully 
functional. E10.5 TLR2+ embryonic phagocytes express a distinct set of genes as 
compared to adult peritoneal macrophages. In addition they possess a TLR2 regulatable 




The autophagic adaptor protein p62 accumulates in detergent-resistant membranes of 
macrophages at the early stages of microbe−host cell interaction upon F. tularensis 
infection in vitro. 
 
Eosinophils isolated from peripheral capillary blood of type 1 diabetic patients express 
high levels of myeloid α-defensins and myeloperoxidase. Thus the transcriptionally 
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